<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>00089 Mid Day Module (Derma+Patho-1) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Mid Day Module
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">50</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 15480,
    "choices": [
      {
        "id": 61880,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Radiosensitive tumor</span></span></span></span></p>"
      },
      {
        "id": 61881,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Spreads through CSF</span></span></span></span></p>"
      },
      {
        "id": 61882,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Surgical treatment not done</span></span></span></span></p>"
      },
      {
        "id": 61883,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Occurs in young age group</span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not true about medulloblastoma?</span></span></p>",
    "unique_key": "Q3819338",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191742,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Surgical treatment not done</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Medulloblastoma </strong>is a <strong>malignant embryonal tumor </strong>that <strong>primarily affects the cerebellum </strong>and is <strong>more common in children</strong>. <strong>Surgical intervention </strong>is a crucial <strong>component of the management of this tumor </strong>and is <strong>performed to remove </strong>as much of the <strong>tumor </strong>as possible. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Medulloblastoma </strong>is a <strong>radiosensitive tumor </strong>and <strong>radiation therapy </strong>is often part of the treatment plan.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Medulloblastoma </strong>commonly <strong>spreads through the cerebrospinal fluid </strong>(CSF), leading to <strong>leptomeningeal dissemination</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Medulloblastoma </strong>predominantly occurs in the <strong>pediatric age group</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Surgical treatment </strong>is indeed <strong>performed for medulloblastoma </strong>and it is an important part of the <strong>management strategy </strong>for this type of <strong>tumor</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 1298</span></span></strong></span></span></p>",
    "correct_choice_id": 61882,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 29684,
    "choices": [
      {
        "id": 118634,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bullous Pemphigoid</span></span></span></p>"
      },
      {
        "id": 118635,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dermatitis Herpetiformis</span></span></span></p>"
      },
      {
        "id": 118636,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">PUPPP </span></span></span></p>"
      },
      {
        "id": 118637,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pemphigoid Gestationis</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old female in her third trimester of pregnancy presents to the dermatology clinic with a 2-week history of itchy, tense blisters centralized on her abdomen, especially around the umbilical area. The blisters are on an erythematous base and she denies any prior history of similar lesions. She has no significant medical history and her pregnancy has been uneventful until these skin changes. Examination does not reveal involvement of the mucous membranes. Based on the clinical presentation, the most likely diagnosis is</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">?</span></span></span></p>",
    "unique_key": "Q3641746",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191743,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D) Pemphigoid Gestationis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pemphigoid gestationis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> / <strong>Gestational pemphigoid / Herpes gestationis</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This <strong>autoimmune blistering</strong> disorder occurs during <strong>pregnancy</strong>, typically in the <strong>second or third trimester</strong>, and is characterized by <strong>pruritic, tense blisters</strong> on the <strong>abdomen</strong>, often starting near the <strong>umbilicus</strong>. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/24/23.jpg\" style=\"height:322px; width:400px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is associated with <strong>antibodies to BP180 and BP230</strong>, similar to <strong>bullous pemphigoid</strong> but is <strong>pregnancy specific.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. Bullous pemphigoid: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Incorrect because it typically affects <strong>older individuals</strong> and is not associated with pregnancy. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. Dermatitis herpetiformis: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Incorrect because this condition presents with <strong>grouped vesicles</strong> and <strong>intense pruritus</strong>, often on <strong>extensor</strong> surfaces, and is associated with <strong>celiac disease. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. PUPPP (Pruritic Urticarial Papules and Plaques of Pregnancy):</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Incorrect because PUPPP usually presents with <strong>urticarial papules and plaques</strong>, starts in the <strong>stretch marks</strong> of the abdomen, and typically does <strong>not</strong> involve the formation of <strong>blisters.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/24/24.jpg\" style=\"height:334px; width:400px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/24/555.jpg\" style=\"height:460px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Pemphigoid gestationis</strong> is a <strong>pruritic</strong>, vesiculobullous disorder of <strong>pregnancy p</strong>resenting with <strong>tense blisters</strong> around the <strong>umbilical area</strong>, typically occurring in the <strong>second or third trimester</strong>, without mucosal involvement.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: </span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rooks Textbook of Dermatology- 9<sup>th</sup> Edition Page No 115.13</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bolognia Textbook of Dermatology 4<sup>th</sup> Edition Page No 472</span></strong></span></span></p>",
    "correct_choice_id": 118637,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 17018,
    "choices": [
      {
        "id": 68032,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It resolves spontaneously in P[ostpartum Period</span></span></span></p>"
      },
      {
        "id": 68033,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Herpes Simplex Virus- 1 is responsible for Cross Reaction with Skin Antigens &amp; Antibody Formation</span></span></span></p>"
      },
      {
        "id": 68034,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Associated with Antibodies against BP180 Antigen</span></span></span></p>"
      },
      {
        "id": 68035,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Variant of Bullous Pemphigoid </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A primigravida in her 3<sup>rd</sup> Trimester develops intensely itchy grouped vesicles in the periumbilical area. A diagnosis of Herpes gestation is made based on these features.&nbsp; Which of the following is INCORRECT statement among the following options regarding this condition?</span></span></span></p>",
    "unique_key": "Q4674961",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191744,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Herpes Simplex Virus- 1 is responsible for Cross Reaction with Skin Antigens &amp; Antibody Formation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">B.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This is an <strong>incorrect</strong> statement. Despite its name, <strong>Herpes gestationis is not caused by Herpes simplex virus</strong>; it&#39;s a <strong>misnomer</strong>. The condition is <strong>autoimmune </strong>in nature</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Herpes gestationis or pemphigoid gestationis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">It </span></strong><span style=\"font-size:12.0pt\">is a variant of <strong>Bullous pemphigoid in pregnancy (NOT due to Herpes virus)</strong> and is associated with antibodies against <strong>BP-180 / BPAG-2</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The initial site of involvement is the <strong>periumbilical </strong>region.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/24/10.jpg\" style=\"height:245px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It presents in the <strong>2<sup>nd</sup> or 3<sup>rd</sup></strong> trimesters with itchy, grouped vesicles (so <strong>Herpes word</strong> used in the name of the disease) in the periumbilical area that later spread to the abdomen, trunk, thighs. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prognosis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It flares in the <strong>intrapartum</strong> / <strong>Delivery</strong> period and tends to <strong>resolves spontaneously </strong>in the <strong>postpartum </strong>period. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Future outcome</span></strong><span style=\"font-size:12.0pt\">: It can <strong>recur </strong>in subsequent pregnancies.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It resolves spontaneously in postpartum period</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The condition <strong>resolves spontaneously in the postpartum period</strong>, although flare-ups can occur with menstruation or subsequent pregnancies.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Associated with antibodies against BP180 antigen</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The condition is <strong>associated with antibodies against BP180 antigen</strong>, which is a <strong>hemidesmosomal protein</strong> involved in the structural integrity of the skin.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Variant of Bullous Pemphigoid</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Pemphigoid Gestationis is considered</span></strong><span style=\"font-size:12.0pt\"> a <strong>variant of Bullous Pemphigoid</strong>, occurring specifically during pregnancy.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pemphigoid Gestationis, the <strong>autoimmune response targets BP180 antigen</strong>, and it is a pregnancy-related <strong>variant of Bullous Pemphigoid</strong> that typically <strong>resolves postpartum</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is not related to Herpes simplex virus infection.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></span></u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Bolognia Textbook of Dermatology- 4<sup>th</sup> Edition Chapter 27 Page No 554</span></span></strong></p>",
    "correct_choice_id": 68033,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 17015,
    "choices": [
      {
        "id": 68020,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dapsone &amp; Granular Deposits of IgA in Dermal Papillae</span></span></span></p>"
      },
      {
        "id": 68021,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Steroids &amp; Linear Deposits of IgA in Basement Membrane Zone</span></span></span></p>"
      },
      {
        "id": 68022,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dapsone &amp; Granular Deposits of IgG in Dermal Papillae</span></span></span></p>"
      },
      {
        "id": 68023,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Steroids &amp; Linear Deposits of IgG in Basement Membrane Zone</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old patient complains of the following intensely itchy rash over her elbows, knees as shown in the image below. She is also a known case of celiac disease &amp; she strictly follows a gluten-free diet, which has resulted in improvement of her diarrhea. However, the following itchy skin lesions have persisted despite her altered diet. What is the Drug of choice for this patient &amp; what is the characteristic DIF finding seen in this patient?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/24/7.jpg\" style=\"height:158px; width:400px\" /></p>\r\n\r\n<p>&nbsp;</p>",
    "unique_key": "Q4646592",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191745,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A) Dapsone &amp; Granular </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deposits of IgA in Dermal Papillae</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dapsone is the drug of choice for <strong>dermatitis herpetiformis</strong> and can provide <strong>rapid relief</strong> of <strong>itching</strong>. The characteristic DIF finding in <strong>dermatitis herpetiformis</strong> is <strong>granular deposits</strong> of <strong>IgA</strong> in the <strong>dermal papillae</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The image and history presented suggest a dermatological condition associated with <strong>celiac disease</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Given the <strong>intense itching</strong>, the locations over <strong>elbows and knees,</strong> and the association with <strong>celiac disease</strong>, the most likely diagnosis is <strong>dermatitis herpetiformis</strong>. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. Steroids &amp; Linear deposits of IgA in Basement membrane Zone.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While steroids may be used in a variety of dermatological conditions, they are not the first-line treatment for dermatitis herpetiformis. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Additionally, <strong>linear deposits of IgA</strong> at the basement membrane zone are indicative of a different condition, such as <strong>linear IgA disease.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. Dapsone&amp; Granular deposits of IgG in dermal papillae. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Although Dapsone is the correct treatment, the characteristic DIF finding in dermatitis herpetiformis is granular IgA, not IgG deposits.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.Steroids &amp; Linear deposits of IgG in Basement membrane Zone. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This option suggests a diagnosis of <strong>Bullous pemphigoid</strong> and does not correspond to <strong>dermatitis herpetiformis</strong>, which is characterized by <strong>IgA deposits</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/24/screenshot-2024-02-24-151046.jpg\" style=\"height:533px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/24/screenshot-2024-02-24-151257.jpg\" style=\"height:701px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For a patient with an <strong>intensely itchy rash</strong> over the <strong>elbows and knees</strong> and a history of <strong>celiac disease</strong>, the drug of choice is <strong>Dapsone</strong>, and the characteristic DIF finding is <strong>granular deposits of IgA</strong> in the dermal <strong>papillae.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rooks Textbook of Dermatology- 9<sup>th</sup> Edition Chapter 50 Page No 50.52-50.54</span></strong></span></span></p>",
    "correct_choice_id": 68020,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 17022,
    "choices": [
      {
        "id": 68048,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">\ufeff\ufeffBullous Pemphigoid &amp; Dapsone</span></span></span></p>"
      },
      {
        "id": 68049,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">\ufeff\ufeffChronic Bullous Disease of Childhood &amp; Azathioprine</span></span></span></p>"
      },
      {
        "id": 68050,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">\ufeff\ufeffChronic Bullous Disease of Childhood &amp; Dapsone</span></span></span></p>"
      },
      {
        "id": 68051,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">\ufeff\ufeffEpidermolysis Bullosa Simplex &amp; Genetic Counselling</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 3-year-old girl child presents to OPD with blisters over perioral area &amp; other periorificial areas which are arranged annularly giving a &lsquo;crown of jewels&rsquo; appearance (Image given below). Direct immunofluorescence microscopy revealed linear IgA deposition in Basement membrane zone. What is the most likely diagnosis &amp; what is the drug of choice in this disease?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/24/5_JWNrTCe.jpg\" style=\"height:199px; width:300px\" /></span></span></span></p>",
    "unique_key": "Q2870990",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191746,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C) Chronic Bullous Disease of Childhood &amp; Dapsone</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The given image showing blisters over <strong>perioral</strong> area &amp; other <strong>periorificial</strong> areas in an annular fashion giving a <strong>&lsquo;crown of jewels&rsquo; </strong>appearance with linear deposition of IgA at the dermo-epidermal junction is diagnostic for linear IgA disease (<strong>LABD</strong>) or chronic bullous disorder of childhood (<strong>CBDC</strong>) or <strong>IgA pemphigoid</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/24/screenshot-2024-02-24-140134.jpg\" style=\"height:393px; width:1000px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is the most common <strong>immunobullous disease</strong> in <strong>infants and children</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It has <strong>Bimodal age group</strong> distribution, i.e., it may occur <strong>&lt;5 years</strong> or at <strong>60-65</strong> years of age. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It occurs in genetically susceptible individuals and can be <strong>triggered</strong> by drugs like <strong>vancomycin, penicillin, and NSAIDs</strong>. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Management</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While <strong>dapsone</strong> is primarily a bactericidal drug, it also has an <strong>anti-inflammatory action</strong> by decreasing the action of neutrophil enzymes. Hence, it is useful in the treatment of IgA pemphigoid.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bullous pemphigoid</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is typically a disease of the elderly and is characterized by <strong>subepidermal blisters </strong>with <strong>linear IgG and C3 deposition</strong>, not IgA. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dapsone is not the first-line treatment for bullous pemphigoid. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic bullous disease of childhood (CBDC), also known as linear IgA disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is the correct diagnosis based on the description, but <strong>azathioprine</strong> is not the drug of choice. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is used as a <strong>second-line</strong> or adjunctive therapy when dapsone is contraindicated or insufficient.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epidermolysis bullosa simplex</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is a <strong>hereditary</strong> condition characterized by <strong>skin fragility</strong> and <strong>blistering</strong> due to cytoskeletal protein <strong>mutations.</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Genetic counselling</span></strong><span style=\"font-size:12.0pt\"> may be of value for <strong>familial planning</strong>, but the condition does not present with linear IgA deposition, nor is it treated with dapsone.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In a <strong>child</strong> presenting with <strong>annularly</strong> arranged <strong>periorificial blisters</strong> and <strong>linear IgA</strong> deposition at the <strong>basement membrane zone</strong>, the most likely diagnosis is Chronic bullous disease of childhood, and the drug of choice is dapsone.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Rooks Textbook of Dermatology- 9<sup>th</sup> Edition Chapter 50 Page N50.33</span></strong></span></span></p>",
    "correct_choice_id": 68050,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 17012,
    "choices": [
      {
        "id": 68008,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bullous Pemphigoid &amp; BP180</span></span></span></p>"
      },
      {
        "id": 68009,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pemphigus Vulgaris &amp; Desmoglein 3</span></span></span></p>"
      },
      {
        "id": 68010,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bullous Pemphigoid &amp; BP280</span></span></span></p>"
      },
      {
        "id": 68011,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pemphigus Vulgaris &amp; Desmoglein 1</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents with the Tense bullous lesions associated with itching. Histopathology revealed Subepidermal blistering. What is the diagnosis of this condition &amp; what are the antigens against which autoantibodies are most commonly seen in this condition?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/24/1.jpg\" style=\"height:315px; width:300px\" /></span></span></span></p>",
    "unique_key": "Q5435004",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191747,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Bullous Pemphigoid &amp; BP180</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Bullous pemphigoid </span></strong><span style=\"font-size:12.0pt\">is a <strong>subepidermal </strong>vesiculobullous disorder where there is at the <strong>dermo-epidermal junction (DEJ). </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Tense bullae </span></strong><span style=\"font-size:12.0pt\">which are associated with <strong>itching</strong> are suggestive of bullous pemphigoid. The bullae are <strong>Nikolsky negative</strong> as <strong>acantholysis is absent.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Autoantibodies against <strong>BP180</strong> are most commonly seen in this condition.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">BP180 is also known as <strong>BPAg2,</strong> and it is seen in 75-90% of bullous pemphigoid patients. Autoantibodies against <strong>BP230or BPAg1</strong> are recognized in 50-70% of bullous pemphigoid patients.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/24/screenshot-2024-02-24-133410.jpg\" style=\"height:323px; width:1000px\" /></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Histopathology of Bullous Pemphigoid showing Subepidermal split:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/24/2.jpg\" style=\"height:300px; width:400px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pemphigus vulgaris &amp; Desmoglein 3.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pemphigus vulgaris is associated with <strong>flaccid blisters</strong>, not tense ones, and the blisters are <strong>intraepidermal</strong> due to <strong>acantholysis</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">The main autoantigen is Desmoglein 3</span></strong><span style=\"font-size:12.0pt\">, a desmosomal protein.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bullous Pemphigoid &amp; BP280</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This option is incorrect because <strong>BP280</strong> (collagen type VII) is not the <strong>primary</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:48px; text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">antigen</span></strong><span style=\"font-size:12.0pt\"> in <strong>Bullous Pemphigoid</strong>; BP180 is the correct antigen.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pemphigus vulgaris &amp; Desmoglein 1<strong>. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While Desmoglein 1 is indeed a target antigen in some cases of Pemphigus vulgaris (usually in combination with Desmoglein 3), the description provided does not match Pemphigus vulgaris, which presents with <strong>supra basal intra-epidermal blistering</strong> and <strong>flaccid bullae</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In a patient with <strong>tense bullae</strong> and histopathology showing <strong>subepidermal blistering</strong>, the diagnosis is <strong>Bullous Pemphigoid</strong>, and the autoantibodies are most commonly directed against the <strong>BP180 antigen</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: </span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rooks Textbook of Dermatology- 9<sup>th</sup> Edition Chapter 50 Page No 50.10</span></strong></span></span></p>",
    "correct_choice_id": 68008,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15482,
    "choices": [
      {
        "id": 61888,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serotonin</span></span></span></span></p>"
      },
      {
        "id": 61889,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetylcholine</span></span></span></span></p>"
      },
      {
        "id": 61890,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GABA (Gamma-aminobutyric acid)</span></span></span></span></p>"
      },
      {
        "id": 61891,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopamine</span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 68-year-old male presents with a resting tremor, bradykinesia, and rigidity. On examination, there is a characteristic &quot;pill-rolling&quot; tremor observed. The patient also exhibits postural instability. Which neurotransmitter is primarily affected in the pathophysiology of Parkinson&#39;s disease?</span></span></p>",
    "unique_key": "Q4098651",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191748,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopamine</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Parkinson&#39;s disease </strong>is a <strong>neurodegenerative disorder </strong>characterized by the <strong>degeneration of dopaminergic neurons </strong>in the <strong>substantia nigra</strong>. The <strong>loss of dopamine-producing neurons </strong>leads to the <strong>classic motor symptoms </strong>of <strong>resting tremor</strong>, <strong>bradykinesia</strong>, and <strong>rigidity</strong>. The characteristic <strong>&quot;pill-rolling&quot; tremor </strong>is often observed, and <strong>postural instability </strong>may develop as the disease progresses.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><u>Explanation</u>:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Changes </strong>in <strong>serotonin levels </strong>are more associated with <strong>mood disorders</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While <strong>imbalances in acetylcholine </strong>and <strong>dopamine </strong>play a role in <strong>movement disorders</strong>, the primary deficit in Parkinson&#39;s disease is related to dopamine deficiency.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>GABA </strong>is an <strong>inhibitory neurotransmitter</strong>, and <strong>alterations in GABAergic transmission </strong>are not the primary cause of Parkinson&#39;s disease.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>neurotransmitter primarily affected in the pathophysiology </strong>of <strong>Parkinson&#39;s disease </strong>is <strong>Dopamine</strong>, which is <strong>depleted </strong>due to <strong>degeneration of dopaminergic neurons </strong>in the <strong>substantia nigra</strong>, leading to characteristic symptoms like <strong>resting tremor</strong>, <strong>bradykinesia, </strong>and <strong>rigidity</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 1293</span></span></strong></span></span></p>",
    "correct_choice_id": 61891,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15466,
    "choices": [
      {
        "id": 61824,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neuroglia </span></span></span></span></p>"
      },
      {
        "id": 61825,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fibroblasts</span></span></span></span></p>"
      },
      {
        "id": 61826,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Axons </span></span></span></span></p>"
      },
      {
        "id": 61827,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Microglia</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old patient sustains a traumatic injury resulting in damage to nervous tissue. The subsequent healing process involves the formation of scar tissue at the site of injury. Which of the following cell types is primarily responsible for the formation of scar tissue during the repair of nervous tissue?</span></span></span></span></p>",
    "unique_key": "Q3914922",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191749,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Neuroglia</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&ldquo;<strong>Gliosis </strong>is the most <strong>important histopathological indicator </strong>of <strong>CNS injury </strong>regardless of its etiology and is characterized by <strong>both hypertrophy </strong>and <strong>hyperplasia</strong>.&rdquo; The chief cell involved in this reaction is an astrocyte. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Please remember that the oligodendrocytes and the ependyma do not participate in active response to injury. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Microglia </strong>is the <strong>fixed macrophage system </strong>in the <strong>CNS</strong>.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neuroglia</span></span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, particularly <strong>astrocytes</strong>, are responsible for the <strong>formation of scar tissue </strong>within the <strong>central nervous system </strong>(CNS) through a <strong>process known as gliosis</strong>, which occurs in response to injury.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Fibroblasts&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are the <strong>primary cell type </strong>responsible for <strong>scar formation in peripheral tissues</strong>, but not typically within the CNS, as they produce collagen and other extracellular matrix components leading to the formation of connective tissue scars.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Axons&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">do not form scar tissue but can be i<strong>nvolved in the regeneration process </strong>in the <strong>peripheral nervous system </strong>under certain conditions.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Microglia&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are the <strong>resident macrophages of the CNS</strong>, involved in the <strong>immune response </strong>and <strong>clean-up after injury </strong>but are not the <strong>primary cells </strong>responsible for scar tissue formation.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>cell type </strong>primarily responsible for the <strong>formation of scar tissue </strong>during the <strong>repair of nervous tissue is Neuroglia</strong>, as <strong>astrocytes</strong>, a type of <strong>glial cell</strong>, play a crucial role in the <strong>gliosis process </strong>that leads to <strong>scar formation in the CNS</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><u>Ref</u>: Robbins 10th 1255</span></span></span></span></strong></p>",
    "correct_choice_id": 61824,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15512,
    "choices": [
      {
        "id": 62008,
        "text": "<p><span style=\"font-size:12pt;\">Neurofibrillary tangles</span></p>"
      },
      {
        "id": 62009,
        "text": "<p><span style=\"font-size:12pt;\">Senile neuritic plaques</span></p>"
      },
      {
        "id": 62010,
        "text": "<p><span style=\"font-size:12pt;\">Amyloid angiopathy</span></p>"
      },
      {
        "id": 62011,
        "text": "<p><span style=\"font-size:12pt;\">Lewy bodies</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 75-year-old patient presents to the neurology clinic with a progressive decline in memory and cognitive function over the past few years. The family reports episodes of visual hallucinations and fluctuations in alertness. Cognitive testing demonstrates impaired memory recall and difficulty with executive functions. An MRI of the brain shows atrophy in the temporal and parietal lobes. Biopsy of brain tissue was done. Which of the following features is not typically associated with the pathology of this patient's condition?</span></p>",
    "unique_key": "Q1646080",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191750,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Lewy bodies</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Lewy bodies </strong>are <strong>not </strong>a characteristic feature of <strong>Alzheimer's disease</strong>. <strong>Alzheimer's disease </strong>is primarily characterized by the <strong>presence of neurofibrillary tangles and senile </strong>(neuritic) <strong>plaques </strong>in the <strong>brain</strong>. <strong>Amyloid angiopathy</strong>, which involves the <strong>deposition of amyloid protein in blood vessel walls</strong>, is also associated with <strong>Alzheimer's disease</strong>. However, <strong>Lewy bodies</strong> are more commonly associated with other <strong>neurodegenerative disorders</strong>, particularly <strong>Lewy body dementia </strong>and <strong>Parkinson's disease dementia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation</u>:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A: Neurofibrillary tangles</strong>: These are <strong>twisted tangles </strong>of <strong>tau protein </strong>within nerve cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B: Senile (neuritic) plaques</strong>: These are <strong>abnormal clusters </strong>of <strong>beta-amyloid protein </strong>that <strong>accumulate between nerve cells</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C: Amyloid angiopathy</strong>: It involves the <strong>deposition of amyloid protein </strong>in <strong>blood vessel walls</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Lewy bodies </strong>are <strong>not </strong>typically associated with the <strong>pathology of Alzheimer's disease</strong>, which is characterized by <strong>neurofibrillary tangles</strong>, <strong>senile neuritic plaques</strong>, and <strong>amyloid angiopathy</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lewy bodies are intracytoplasmic eosinophilic inclusions composed of alpha-synuclein, seen in:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Parkinson\u2019s disease</span></li><li><span style=\"font-size:12.0pt;\">Dementia with Lewy bodies (DLB)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup> / 1275</strong></span></p>",
    "correct_choice_id": 62011,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15460,
    "choices": [
      {
        "id": 61800,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schwannoma </span></span></span></p>"
      },
      {
        "id": 61801,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lymphoma</span></span></span></p>"
      },
      {
        "id": 61802,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leukemia </span></span></span></p>"
      },
      {
        "id": 61803,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Angiofibroma</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old patient presents with unilateral sensorineural hearing loss and persistent tinnitus. Physical examination reveals a non-tender mass in the vicinity of cranial nerve VIII. An MRI indicates a well-circumscribed mass in the internal acoustic meatus, and a subsequent biopsy is performed. Histologically, the tissue demonstrates distinct regions of cellularity with areas showing dense proliferation of spindle cells, while others show less density. There is also evidence of nuclear palisading. Which of the following is the most likely diagnosis?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/10/picture1_GWIBY0y.jpg\" style=\"height:254px; width:350px\" /></span></span></p>",
    "unique_key": "Q5541984",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191751,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Schwannoma </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This tumor <strong>arises from Schwann cells</strong>, which <strong>produce the myelin sheath </strong>of <strong>peripheral nerves</strong>. The <strong>biopsy </strong>is <strong>consistent with a schwannoma </strong>due to the <strong>presence of Antoni A areas </strong>(hypercentric, organized cellularity with nuclear palisading) and <strong>Antoni B areas </strong>(hypocellular, less organized regions).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Lymphoma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Lymphomas are <strong>neoplasms of the lymphatic system </strong>and would <strong>present histologically </strong>with an <strong>infiltration of lymphoid cells</strong>, which does not correspond to the nuclear palisading and alternating cellularity described in the stem.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Leukemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a <strong>hematopoietic stem cell malignancy </strong>primarily <strong>affecting the bone marrow </strong>and <strong>blood</strong>. <strong>Histology </strong>of a <strong>solid mass </strong>would <strong>not reveal the characteristic findings of leukemia</strong>, such as <strong>blasts or excessive leukocytes</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Angiofibroma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Angiofibroma, often a <strong>benign tumor of adolescent males</strong>, would show a <strong>stromal </strong>and <strong>vascular component histologically</strong>, which is not described in the biopsy findings of the question stem.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The characteristic <strong>histological features </strong>of <strong>schwannomas </strong>are <strong>Antoni A areas</strong>, with <strong>hypercellular tissue </strong>and <strong>nuclear palisading</strong>, and <strong>Antoni B areas</strong>, which are <strong>less cellular</strong>. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th/e p1237</span></strong></span></span></p>",
    "correct_choice_id": 61800,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16284,
    "choices": [
      {
        "id": 65096,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Benign and malignant thyroid cancers </span></span></span></span></p>"
      },
      {
        "id": 65097,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Benign and malignant pheochromocytoma </span></span></span></span></p>"
      },
      {
        "id": 65098,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Benign and malignant liver tumors </span></span></span></span></p>"
      },
      {
        "id": 65099,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Benign and malignant renal tumors</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mitotic figures and giant cells are seen in which of the following tumor?</span></span></span></span></p>",
    "unique_key": "Q2140031",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191752,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Benign and malignant pheochromocytoma</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pheochromocytomas </strong>are <strong>difficult to diagnose </strong>exclusively from the <strong>histological appearance</strong>. <strong>Cellular </strong>and <strong>nuclear pleomorphism</strong>, including the <strong>presence of giant cells</strong>, and <strong>mitotic figures </strong>are often seen in <strong>benign pheochromocytomas</strong>. So, the definitive diagnosis of malignancy in pheochromocytomas is based exclusively on the presence of metastases.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pheochromocytomas</strong>, whether <strong>benign or malignant</strong>, can <strong>exhibit cellular and nuclear pleomorphism</strong>, which includes the <strong>presence of giant cells </strong>and <strong>mitotic figures</strong>. The presence of these features does not correlate with malignancy, as malignancy in pheochromocytoma is defined by the presence of metastasis.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Thyroid cancers </strong>can indeed <strong>present with mitotic figures</strong>, especially in <strong>more aggressive forms </strong>such as <strong>anaplastic thyroid carcinoma</strong>. However, giant cells are particularly characteristic of certain inflammatory conditions such as subacute thyroiditis, rather than thyroid neoplasms.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Benign and malignant liver tumors </strong>\\ such as <strong>hepatocellular carcinoma </strong>can <strong>show mitotic figures</strong>, indicating a <strong>high proliferative rate</strong>. However, giant cells are more typical of specific liver pathologies such as giant cell hepatitis, not necessarily of benign or malignant liver tumors.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In <strong>renal tumors</strong>, <strong>mitotic figures </strong>are also indicative of a <strong>higher grade of malignancy</strong>, especially in <strong>clear cell renal carcinoma</strong>. Giant cells are not a characteristic feature of common benign or malignant renal tumors.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>histological presence </strong>of <strong>mitotic figures </strong>and <strong>giant cells in pheochromocytomas </strong>is <strong>not </strong>indicative of <strong>malignancy</strong>; instead, <strong>malignancy </strong>is confirmed by the <strong>presence of metastatic disease</strong>. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 1127</span></span></strong></span></span></p>",
    "correct_choice_id": 65097,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16244,
    "choices": [
      {
        "id": 64936,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Papillary cancer</span></span></span></span></p>"
      },
      {
        "id": 64937,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medullary cancer</span></span></span></span></p>"
      },
      {
        "id": 64938,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follicular cancer</span></span></span></span></p>"
      },
      {
        "id": 64939,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anaplastic cancer</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common thyroid cancer after radiation exposure is:</span></span></span></span></p>",
    "unique_key": "Q4142050",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191753,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Papillary cancer </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There is a marked <strong>increase </strong>in the <strong>incidence of papillary carcinomas </strong>among <strong>children </strong>exposed to <strong>ionizing radiation </strong>(particularly during the first 2 decades of life).</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Deficiency of dietary iodine </strong>(and so, goiter) is <strong>linked with a higher frequency </strong>of <strong>follicular carcinomas</strong>.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Exposure to ionizing radiation</strong>, especially during the <strong>first two decades of life</strong>, significantly <strong>increases the risk of developing papillary thyroid carcinoma</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Medullary cancer:</strong> Medullary thyroid cancer <strong>arises from parafollicular C-cells </strong>and is typically associated with <strong>genetic mutations in the RET proto-oncogene</strong>, not with radiation exposure.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Follicular cancer:</strong> While <strong>not </strong>associated with <strong>radiation exposure</strong>, the incidence of follicular carcinoma is higher in areas with iodine deficiency.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anaplastic cancer:</strong> Anaplastic thyroid cancer is a <strong>rare and aggressive form of thyroid cancer </strong>that generally <strong>occurs in the elderly population </strong>and is not associated with radiation exposure.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Papillary thyroid carcinoma </strong>is the <strong>most common thyroid cancer </strong>associated with <strong>childhood exposure </strong>to <strong>ionizing radiation</strong>, which can significantly <strong>increase the risk of this cancer</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 1086</span></span></strong></span></span></p>",
    "correct_choice_id": 64936,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16240,
    "choices": [
      {
        "id": 64920,
        "text": "<p><span style=\"font-size:12.0pt;\">Associated with BRAF mutation</span></p>"
      },
      {
        "id": 64921,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Psammoma body present in 50% cases</span></p>"
      },
      {
        "id": 64922,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Early metastasis with poor prognosis</span></p>"
      },
      {
        "id": 64923,
        "text": "<p><span style=\"font-size:12.0pt;\">Spreads by the lymphatic route</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">About papillary carcinoma of thyroid, all are true except:</span></p>",
    "unique_key": "Q3349935",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191754,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. C) Early metastasis with poor prognosis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Although <strong>papillary thyroid carcinoma </strong>can <strong>metastasize early</strong>, particularly to <strong>regional lymph nodes</strong>, it usually maintains a <strong>good prognosis </strong>and is often curable.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">This does not worsen prognosis significantly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Even with lymph node metastasis, survival remains excellent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Distant metastasis (to lungs or bone) is rare, and when present, prognosis may be slightly worse but still much better than most other cancers.</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;Associated with BRAF mutation:</strong> Papillary carcinoma of the thyroid is associated with BRAF gene mutation.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Psammoma body present in 50% cases:</strong> Psammoma bodies are calcifications that are often found in papillary thyroid carcinoma but may not be present in as many as 50% of cases.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Spreads by the lymphatic route:</strong> This is <strong>true</strong>. Papillary thyroid carcinoma commonly spreads to regional lymph nodes via lymphatics.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">This typically involves:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Cervical lymph nodes (neck)</span></li><li><span style=\"font-size:12.0pt;\">Jugular lymph chain</span></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Papillary carcinoma </strong>of the <strong>thyroid </strong>typically has a <strong>favorable prognosis</strong>, even with <strong>early lymphatic spread</strong>, <strong>contrasting </strong>with other <strong>cancers </strong>where <strong>early metastasis </strong>often correlates with a <strong>poor prognosis</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup> 1086</strong></span></p>",
    "correct_choice_id": 64922,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7767,
    "choices": [
      {
        "id": 31036,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atopic Dermatitis (AD) is the diagnosis</span></span></span></p>"
      },
      {
        "id": 31037,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">UK refinement of Hanifin &amp; Rajka criteria is used in the diagnosis of AD</span></span></span></p>"
      },
      {
        "id": 31038,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It has a Flexural distribution in Infantile Phase</span></span></span></p>"
      },
      {
        "id": 31039,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Face is the First Site of involvement of AD in infants</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 10-year-old child presented to the dermatology clinic with itchy and hyperpigmented plaques in cubital and popliteal fossa as shown in image. Her personal history reveals a chronic &amp; recurrent course of these lesions; family history is positive for asthma. Identify the FALSE statement related to this patient? </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/07/picture4_MDg49a8.jpg\" style=\"height:199px; width:300px\" /></p>",
    "unique_key": "Q3969233",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191755,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) It has a Flexural Distribution in Infantile Phase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span style=\"font-size:12.0pt\">C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The image showing <strong>Scratch Marks </strong>&amp;&nbsp;<strong>Excoriations </strong>due to <strong>Pruritic Lesion </strong>at a <strong>Flexural Site</strong> along with a personal history of chronic &amp; recurrent course &amp; a family history of <strong>atopy</strong> (Asthma) is suggestive of <strong>Atopic Dermatitis</strong> (AD) or <strong>Atopic Eczema (AE) (Option A)</strong></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Flexural distribution&nbsp;</span></strong><span style=\"font-size:12.0pt\">is seen in Childhood &amp;&nbsp;<strong>Adult Phase </strong>&amp; <strong>Extensor distribution </strong>in <strong>Infantile Phase.</strong></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is a <strong>Chronic </strong>or chronically relapsing <strong>Inflammatory </strong>Condition. </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The first site of involvement in <strong>infants</strong> with <strong>atopic eczema</strong> is the <strong>face.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atopic eczema can be divided into <strong>3 phases:</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Infantile</span></strong></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Childhood</span></strong></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Adult</span></strong></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/screenshot-2024-02-21-162724.jpg\" style=\"height:277px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Atopic eczema&nbsp;</span></strong><span style=\"font-size:12.0pt\">infantile variant with <strong>face affected</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/picture65.jpg\" style=\"height:323px; width:300px\" /></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Erythematous papules&nbsp;</span></strong><span style=\"font-size:12.0pt\">or <strong>papulovesicular lesions</strong>, which frequently <strong>begin</strong> in <strong>early childhood</strong>, are how it manifests.</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Later, the lesions <strong>develop excoriation</strong> and <strong>Lichenification</strong>. It frequently has a relationship with <strong>secondary infections </strong>&amp; <strong>skin dryness</strong>.</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>UK refinement </strong>of<strong> Hanifin </strong>&amp;<strong> Rajka criteria</strong> is used in the diagnosis of <strong>Atopic dermatitis.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: UK refinement of Hanifin &amp; Rajka&rsquo;s diagnostic criteria of atopic dermatitis (Eczema):</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">An <strong>itchy skin</strong> condition (or <strong>parental report</strong> of <strong>scratching</strong> or <strong>rubbing</strong> in a <strong>child</strong>)</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Plus three&nbsp;</span></strong><span style=\"font-size:12.0pt\">or more of the following:</span></span></span></li>\r\n</ul>\r\n\r\n<ol style=\"margin-left:40px\">\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Onset <strong>below age 2 years</strong> (not used if child is under 4 years)</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">History of <strong>skin crease involvement</strong> (including cheeks in children under 10 years)</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">History of a <strong>generally dry skin</strong></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Personal history of other atopic disease (or history of any atopic disease in a first degree relative in children <strong>under 4 years</strong>)</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Visible <strong>flexural dermatitis</strong> (or <strong>dermatitis</strong> of <strong>cheeks</strong>/<strong>forehead</strong> and <strong>outer limbs</strong> in children <strong>under 4 years</strong>)</span></span></span><br />\r\n\t&nbsp;</li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Clinical features</span></strong><span style=\"font-size:12.0pt\"> include:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Dennie morgan&nbsp;</span></strong><span style=\"font-size:12.0pt\">fold under <strong>lower eyelid</strong></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Allergic shiners&nbsp;</span></strong><span style=\"font-size:12.0pt\">&ndash; <strong>periorbital pigmentation</strong></span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Allergic salute&nbsp;</span></strong><span style=\"font-size:12.0pt\">&ndash; <strong>horizontal groove</strong> on <strong>dorsum</strong> of <strong>nasal bridge</strong></span></span></span><br />\r\n\t&nbsp;</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Dennie morgan fold</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/picture66.jpg\" style=\"height:255px; width:300px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Complications:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Staphylococcus aureus&nbsp;</span></strong><span style=\"font-size:12.0pt\">is the most common organism to cause <strong>secondary infections</strong> in the <strong>lesions</strong> of <strong>atopic dermatitis</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Atopic dermatitis in infants&nbsp;</span></strong><span style=\"font-size:12.0pt\">typically involves the <strong>face </strong>and<strong> extensor surfaces</strong> rather than <strong>flexural areas</strong>, which are more commonly <strong>affected</strong> in <strong>older children</strong> and <strong>adults</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><u>Ref</u>:&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">Rooks Textbook of Dermatology- 9th Edition Volume 2 Chapter 41 Page No 41.1, 41.2, 41.13-19 </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Rooks Textbook of Dermatology- 9<sup>th</sup> Edition V</span></strong><strong><span style=\"font-size:12.0pt\">olume 3 Chapter 149 Page No 149.21</span></strong></span></span></p>",
    "correct_choice_id": 31038,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7794,
    "choices": [
      {
        "id": 31144,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Color of the Human Skin depends upon the Number of Melanocytes</span></span></span></p>"
      },
      {
        "id": 31145,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Melasma in Pregnancy is called as Chloasma</span></span></span></p>"
      },
      {
        "id": 31146,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The Ratio of the Epidermal Melanin Unit is 36 Keratinocytes: 1 Melanocyte</span></span></span></p>"
      },
      {
        "id": 31147,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bindi Leukoderma is caused by Para-Tertiary Butyl-Phenol (PTBP)</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Identify the INCORRECT statement among the following options?</span></span></span></p>",
    "unique_key": "Q8584432",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191756,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A) Color of the Human Skin depends upon the Number of Melanocytes.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A: Color of the human skin depends upon the number of melanocytes</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The color of the human skin <strong>does NOT</strong> depend on the number of melanocytes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The following factors determine the skin&#39;s color:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The concentration of <strong>melanin</strong> within melanocytes</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The <strong>quantity and size </strong>of <strong>melanosomes</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The extent to which melanin is <strong>transferred</strong> into keratinocytes.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Melanin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">, a pigment produced by <strong>melanocytes</strong>, is what gives skin its color.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Melanocytes are <strong>dendritic cells </strong>that are found in the <strong>stratum basale </strong>layer of epidermis and are descended from <strong>neural crest </strong>cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The <strong>cell organelles</strong> known as <strong>melanosomes</strong> are where each <strong>melanocyte stores the melanin</strong> it produces. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">These melanosomes are distributed to the <strong>36 keratinocytes</strong> that make up the &quot;<strong>epidermal melanin</strong>&quot; <strong>unit</strong> via the <strong>dendritic processes</strong> of <strong>melanocytes</strong>. (The <strong>ratio</strong> of the <strong>epidermal melanin</strong> <strong>unit</strong> is <strong>36 keratinocytes: 1 melanocyte</strong>)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: <strong>Melasma</strong> in <strong>pregnant women</strong> is called as <strong>Chloasma</strong> or <strong>mask of pregnancy</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clinical Image&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">depicting <strong>Melasma</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/07/picture1_X44IgpQ.jpg\" style=\"height:235px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The <strong>third trimester</strong> of <strong>pregnancy</strong> is when <strong>chloasma</strong> is <strong>most prevalent</strong> and is <strong>most noticeable</strong> in <strong>brunettes</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It <strong>results</strong> from elevated levels of <strong>estrogen</strong> and <strong>progesterone</strong> stimulating <strong>melanocyte activity.</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Histopathology shows <strong>no increase</strong> in <strong>number</strong> but <strong>hyper-functional melanocytes</strong>. Once the <strong>pregnancy</strong> is <strong>over</strong>, it <strong>resolves naturally</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The <strong>most frequent</strong> cause of <strong>chronic facial melanosis</strong> is <strong>melasma</strong>. <strong>Hyperpigmented macules</strong> that are more <strong>pronounced</strong> <strong>after exposure</strong> to <strong>sunlight</strong> are its <strong>primary symptom</strong>. <strong>Upper lip</strong>, <strong>malar</strong>, <strong>forehead</strong>, and <strong>chin</strong> are the <strong>main areas</strong> of the body <strong>affected</strong> by this <strong>hyper melanosis</strong>. <strong>Women</strong> between the <strong>ages</strong> of <strong>20 and 40</strong> are more likely to have it. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is due to <strong>increased levels</strong> of <strong>estrogen &amp; progesterone</strong>, stimulating the <strong>activity of melanocytes</strong>. Histopathology shows <strong>no increase</strong> in number but <strong>hyper functional melanocytes</strong>. It resolves on its own <strong>after pregnancy</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is frequently seen in women on <strong>OCPs.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Woods lamp</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>examination</strong> is useful to differentiate various types of <strong>Melasma</strong>, level of <strong>pigmentation</strong> &amp; <strong>treatment response:</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/screenshot-2024-01-30-123711.jpg\" style=\"height:223px; width:1000px\" /></strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Melasma is <strong>more Chronic</strong> &amp; requires treatment with <strong>depigmenting agents</strong> like:</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Kligman triple combination</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">- Topical Hydroquinone + Tretinoin + Steroid compound cream (First Line)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hydroquinone</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> (reduces Tyrosinase Activity)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Kojic Acid (Tyrosinase Inhibitor)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chemical peels</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D: Para-Tertiary Butyl Phenol&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">is the culprit behind bindi <strong>Leukoderma</strong> (PTBP). It is present in adhesive sticker <strong>Bindi.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clinical Image depicting Bindi Leucoderma</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/07/picture2_90Ys6Mx.jpg\" style=\"height:211px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This condition is known as <strong>chemical or contact leukoderma</strong>, in which the <strong>chemical increases sensitivity</strong> and causes the <strong>melanocytes</strong> in the <strong>area</strong> of contact to undergo <strong>apoptosis.</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Additionally, there is proof that <strong>azo dyes</strong>, which share structural similarities with <strong>tyrosine</strong> and compete with it for the <strong>binding</strong> of the <strong>tyrosinase enzyme</strong>, can directly <strong>inhibit melanogenesis.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>correct identification</strong> of <strong>skin colour</strong> being determined by <strong>melanin production</strong> and <strong>NOT</strong> by the <strong>number</strong> of <strong>melanocytes</strong> is crucial for <strong>understanding</strong> the <strong>pathophysiology</strong> of <strong>pigmentary disorders</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">:&nbsp;</span></strong></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rook&#39;s Textbook of Dermatology 9th Edition Page No 2.17, 68.11, 75.19, 88.10</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Bolognia Textbook of Dermatology 4<sup>th</sup> Edition Page No 1119-1121</span></strong></span></span></p>",
    "correct_choice_id": 31144,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16954,
    "choices": [
      {
        "id": 67776,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Face and Scalp are the most frequently involved sites.</span></span></span></p>"
      },
      {
        "id": 67777,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Non Scarring Alopecia is seen associated with Discoid Lupus Erythematosus.</span></span></span></p>"
      },
      {
        "id": 67778,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Topical Steroids are the First Line treatment for Localised Lesions</span></span></span></p>"
      },
      {
        "id": 67779,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Antimalarials can be used for treatment</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All&nbsp;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">of the following statements are correct regarding Discoid Lupus Erythematosus except:</span></span></p>",
    "unique_key": "Q6213587",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191757,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Non Scarring Alopecia is seen associated with Discoid Lupus Erythematosus.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Non scarring alopecia is seen associated with Discoid Lupus Erythematosus. </span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A benign inflammatory skin condition called <strong>discoid lupus erythematosus</strong> usually affects the <strong>face and scalp</strong>, associated <strong>scarring alopecia (Option B)</strong> is seen.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It has distinct, red, <strong>scaly patches</strong> that can vary in size. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">These patches heal with atrophy, scarring, and <strong>pigmentary changes</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most common type of disease is the circumscribed or <strong>discoid form</strong>, which mainly affects the <strong>cheeks, nose bridge</strong>, <strong>ears,</strong> side of the neck, and scalp. (<strong>Option A)</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The scalp-specific discoid lupus erythematosus with <strong>follicular plugging (Scarring</strong> alopecia) is depicted in the image below.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/screenshot-2024-01-30-121855.jpg\" style=\"height:186px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The skin lesions in <strong>discoid or chronic cutaneous lupus erythematosus</strong> are well-defined erythematous patches with <strong>adherentscaling</strong> and <strong>peripheral hyperpigmentation</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The underside of the scale reveals <strong>horny plugs</strong> that have occupied <strong>dilated pilosebaceous</strong> canals when the scale is removed. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This sign is known as the <strong>&quot;tin-tack&quot; sign.</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>first-line</strong> treatment for localized lesions is <strong>topical corticosteroids. (Option C)</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Hydroxychloroquine and chloroquine&nbsp;</span></strong><span style=\"font-size:12.0pt\">are oral <strong>antimalarial </strong>drugs that can be used along with oral steroids and have a good response rate. <strong>(Option D)</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><u><span style=\"font-size:12.0pt\">: </span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Discoid lupus erythematosus (DLE)</strong> typically presents with <strong>scarring alopecia</strong> when it affects the scalp, distinguishing it from non-scarring forms of alopecia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Rook&#39;s Textbook of Dermatology 9th Edition, Chapter 51, Page no&rsquo;s 51.4-51.10</span></span></strong></p>",
    "correct_choice_id": 67777,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 36136,
    "choices": [
      {
        "id": 144339,
        "text": "<p><span style=\"background-color:white\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#0d0d0d\">B1 (thiamine)</span></span></span></span></span></span>&nbsp;</p>"
      },
      {
        "id": 144340,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#0d0d0d\">B2 (riboflavin) </span></span></span></p>"
      },
      {
        "id": 144341,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#0d0d0d\">B3 (niacin) </span></span></span></p>"
      },
      {
        "id": 144342,
        "text": "<p><span style=\"background-color:white\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#0d0d0d\">B6 (pyridoxine)</span></span></span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"background-color:white\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#0d0d0d\">A 60-year-old man, with a background of chronic obstructive pulmonary disease, long-term alcohol abuse, and homelessness, is hospitalized due to acute pneumonia. During a ward examination, you observe a brownish-red discoloration on his face, neck, forearms, and lower legs, accompanied by skin scaling and cracks. He reports difficulties with eating and drinking, ongoing vomiting, diarrhea, and appears somewhat disoriented. Which vitamin deficiency might be responsible for these symptoms?</span></span></span></span></span></span></p>",
    "unique_key": "Q5725873",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191758,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Arial&quot;,sans-serif\">Correct Answer: C. B3 (niacin)</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Arial&quot;,sans-serif\">Explanation<br />\r\n&bull;&nbsp;&nbsp; &nbsp;<strong><span style=\"font-family:&quot;Arial&quot;,sans-serif\">Niacin (Vitamin B3) deficiency</span></strong> leads to <strong><span style=\"font-family:&quot;Arial&quot;,sans-serif\">pellagra</span></strong>, which is characterized by the four Ds: <strong><span style=\"font-family:&quot;Arial&quot;,sans-serif\">Dermatitis, Diarrhea, Dementia</span></strong>, and potentially <strong><span style=\"font-family:&quot;Arial&quot;,sans-serif\">Death</span></strong> if untreated.&nbsp;<br />\r\n&bull;&nbsp;&nbsp; &nbsp;The skin changes noted as brown-red discoloration with scaling and cracking, particularly when exposed to sunlight, are indicative of dermatitis.&nbsp;<br />\r\n&bull;&nbsp;&nbsp; &nbsp;The gastrointestinal symptoms like vomiting and diarrhea, along with neurological signs such as disorientation, point towards the systemic effects of niacin deficiency, encompassing both digestive and mental disturbances.</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Arial&quot;,sans-serif\">Other Options<br />\r\nOption A. <strong><span style=\"font-family:&quot;Arial&quot;,sans-serif\">B1 (thiamine): </span></strong>Deficiency leads to <strong><span style=\"font-family:&quot;Arial&quot;,sans-serif\">beriberi or Wernicke-Korsakoff syndrome</span></strong>, primarily affecting the <strong><span style=\"font-family:&quot;Arial&quot;,sans-serif\">cardiovascular and nervous systems</span></strong>, respectively. It does not typically cause the dermatological or extensive gastrointestinal symptoms seen in this patient.</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Arial&quot;,sans-serif\">Option B. <strong><span style=\"font-family:&quot;Arial&quot;,sans-serif\">B2 (riboflavin</span></strong>): Deficiency of riboflavin can cause <strong><span style=\"font-family:&quot;Arial&quot;,sans-serif\">angular cheilitis, glossitis, and seborrheic dermatitis</span></strong>, but these symptoms are distinct from the extensive skin discoloration and systemic symptoms described.</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Arial&quot;,sans-serif\">Option D. <strong><span style=\"font-family:&quot;Arial&quot;,sans-serif\">B6 (pyridoxine)</span></strong>: Deficiency primarily presents with <strong><span style=\"font-family:&quot;Arial&quot;,sans-serif\">peripheral neuropathy, irritability, depression, and dermatitis</span></strong>, but unlike niacin deficiency, it does not typically result in the severe digestive and mental symptoms observed in this case.</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Arial&quot;,sans-serif\">Educational Objective:</span></strong><br />\r\n<span style=\"font-family:&quot;Arial&quot;,sans-serif\">&bull;&nbsp;&nbsp; &nbsp;The crucial fact to remember from this case is that<strong><span style=\"font-family:&quot;Arial&quot;,sans-serif\"> niacin deficiency, or pellagra,</span></strong> presents with a characteristic combination of symptoms including <strong><span style=\"font-family:&quot;Arial&quot;,sans-serif\">dermatitis</span></strong> (skin discoloration and scaling), <strong><span style=\"font-family:&quot;Arial&quot;,sans-serif\">diarrhea, dementia (disorientation),</span></strong> and can be fatal if untreated.&nbsp;</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Arial&quot;,sans-serif\">Ref: Rook&#39;s Textbook of Dermatology 9th Edition Chapter 63 Page Number 63.4</span></span></span></p>",
    "correct_choice_id": 144341,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16234,
    "choices": [
      {
        "id": 64896,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maturity onset DM</span></span></span></span></p>"
      },
      {
        "id": 64897,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type I DM</span></span></span></span></p>"
      },
      {
        "id": 64898,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type II DM</span></span></span></span></p>"
      },
      {
        "id": 64899,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the above</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 62-year-old male presents to the clinic with complaints of bilateral lower extremity swelling and fatigue for the past several months. He has a past medical history significant for poorly controlled diabetes mellitus, hypertension, and obesity. Laboratory investigations reveal elevated serum creatinine and proteinuria. A renal biopsy is performed, which demonstrates deposition of amyloid proteins in the glomeruli. Which of the following types of diabetes mellitus is most commonly associated with this renal complication?</span></span></span></span></p>",
    "unique_key": "Q5099913",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191759,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Type II DM </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Type II DM </strong>is associated with the <strong>deposition of amyloid in the pancreatic islets</strong>, contributing to <strong>&beta;-cell dysfunction</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Maturity onset diabetes of the young </strong>(MODY) is characterized by <strong>monogenic defects of &beta;-cell function </strong>but is not typically associated with amyloid deposition in the islets.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Type I DM </strong>is an <strong>autoimmune disorder </strong>leading to <strong>&beta;-cell destruction </strong>and does not typically involve amyloid deposition.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Amyloid deposition </strong>in the <strong>islets of Langerhans </strong>is a feature specifically associated with <strong>Type II diabetes mellitus</strong>, which can contribute to the <strong>dysfunction of insulin-secreting pancreatic &beta;-cells</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 261</span></span></strong></span></span></p>",
    "correct_choice_id": 64898,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16225,
    "choices": [
      {
        "id": 64860,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased insulin release</span></span></span></span></p>"
      },
      {
        "id": 64861,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Steatosis</span></span></span></span></p>"
      },
      {
        "id": 64862,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatocyte dysfunction</span></span></span></span></p>"
      },
      {
        "id": 64863,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased &lsquo;C&rsquo; peptide level</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the primary contributor to insulin resistance in liver disease?</span></span></p>",
    "unique_key": "Q6672051",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191760,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Steatosis </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>accumulation of fat in the liver</strong>, or <strong>hepatic steatosis</strong>, is closely associated with <strong>insulin resistance</strong>. It <strong>impairs the liver&#39;s response </strong>to <strong>insulin</strong>, particularly affecting the <strong>inhibition of gluconeogenesis </strong>and <strong>increasing insulin resistance </strong>in <strong>peripheral tissues</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Decreased insulin release:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This refers to a <strong>problem with insulin secretion </strong>from the <strong>pancreas</strong>, not resistance at the level of hepatic or peripheral tissues and does not directly relate to liver disease.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hepatocyte dysfunction:</strong> While <strong>hepatocyte dysfunction </strong>can contribute to <strong>metabolic disturbances</strong>, it is a broader term that includes various liver impairments, not specific to insulin resistance.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Decreased &lsquo;C&rsquo; peptide level:</strong> <strong>C-peptide </strong>is a <strong>byproduct of insulin production</strong>. <strong>Lower levels </strong>may indicate <strong>reduced insulin secretion </strong>but are not a direct cause of insulin resistance in the liver.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hepatic steatosis</strong>, or <strong>fatty liver disease</strong>, is a significant <strong>contributor to insulin resistance</strong>, which <strong>impairs both the liver&#39;s response </strong>to <strong>insulin </strong>and the <strong>peripheral action of insulin</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbin 10th/ 1140, Joslin&rsquo;s Diabetes Mellitus 14/e p436</span></span></strong></span></span></p>",
    "correct_choice_id": 64861,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15019,
    "choices": [
      {
        "id": 60036,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary biliary cirrhosis </span></span></span></span></p>"
      },
      {
        "id": 60037,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary sclerosing cholangitis </span></span></span></span></p>"
      },
      {
        "id": 60038,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Extrahepatic biliary fibrosis </span></span></span></span></p>"
      },
      {
        "id": 60039,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congenital hepatic fibrosis</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 38-year-old patient presents with recurrent episodes of jaundice and pruritus. Liver biopsy reveals characteristic &quot;onion skin fibrosis&quot; around the bile ducts. Laboratory tests show elevated alkaline phosphatase levels. Which of the following conditions is most likely associated with the histological finding described?</span></span></p>",
    "unique_key": "Q1972053",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191761,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Primary sclerosing cholangitis </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&quot;Onion skin fibrosis&quot; </strong>refers to a characteristic <strong>histological finding in primary sclerosing cholangitis</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Primary sclerosing cholangitis </strong>is a <strong>chronic, progressive cholestatic liver disease </strong>characterized by&nbsp;</span></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>inflammation </strong>and <strong>fibrosis of the intrahepatic </strong>and <strong>extrahepatic bile ducts</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Primary biliary cirrhosis </strong>is a <strong>distinct autoimmune liver disease </strong>characterized by the <strong>destruction of small bile ducts </strong>within the <strong>liver</strong>. <strong>&quot;Onion skin fibrosis</strong>&quot; is <strong>not a typical histological finding </strong>in <strong>primary biliary cirrhosis</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Extrahepatic biliary fibrosis</strong>: This term is nonspecific and not commonly used as a diagnosis.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Congenital hepatic fibrosis </strong>is a <strong>developmental disorder of the liver </strong>and is not associated with onion skin fibrosis.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary sclerosing cholangitis&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is <strong>associated with characteristic &quot;onion skin fibrosis</strong>&quot; <strong>around bile ducts </strong>and <strong>elevated alkaline phosphatase levels</strong>, reflecting bile duct inflammation and fibrosis.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th 861</span></span></strong></span></span></p>",
    "correct_choice_id": 60037,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14987,
    "choices": [
      {
        "id": 59908,
        "text": "<p><span style=\"font-size:12pt;\">Prussian blue</span></p>"
      },
      {
        "id": 59909,
        "text": "<p><span style=\"font-size:12pt;\">Alcian blue</span></p>"
      },
      {
        "id": 59910,
        "text": "<p><span style=\"font-size:12.0pt;\">Von kossa</span></p>"
      },
      {
        "id": 59911,
        "text": "<p><span style=\"font-size:12.0pt;\">Crystal violet</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 52-year-old male with a history of diabetes mellitus and joint pains presents with skin hyperpigmentation and elevated serum ferritin. A liver biopsy is performed, and the resulting slide is shown. The patient's liver biopsy is notable for a blue staining pattern within the hepatocytes. Given below is the histopathology of liver biopsy of a patient with hemochromatosis. Which of the following stain has been used?&nbsp;<i>&nbsp;</i></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/08/io58.jpg\" alt=\"\" width=\"300\" height=\"234\"></p>",
    "unique_key": "Q5803106",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191762,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. A) Prussian blue</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">This <strong>iron stain</strong>, also known as <strong>Perls' Prussian blue</strong>, detects <strong>ferric iron by turning it blue</strong>. It is specifically <strong>used for the detection of iron overload in tissues</strong>, as seen in <strong>hemochromatosis.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Explanation</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option B: Alcian blue:&nbsp;Alcian blue stains acidic polysaccharides </strong>and <strong>glycosaminoglycans in tissues blue</strong>, which is used to <strong>identify mucopolysaccharides</strong>. It is not used for iron staining.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option C: Von Kossa:&nbsp;</strong>The <strong>Von Kossa stain </strong>is used to <strong>detect calcium salts</strong>, which <strong>appear black under microscopy. </strong>This would not be the appropriate stain for identifying iron deposits in the liver.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option D: Crystal violet:&nbsp;Crystal violet </strong>is a <strong>basic dye </strong>that <strong>stains the components of cells purple </strong>or <strong>blue-violet </strong>and is often <strong>used in Gram staining of bacteria</strong>. It is not used for the detection of iron in tissue samples.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">This <strong>stain is used to detect iron deposits </strong>in <strong>tissues </strong>and is characteristic of the <strong>pathology seen in hemochromatosis</strong>, where <strong>iron accumulation occurs </strong>within the hepatocytes.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 849</strong></span></p>",
    "correct_choice_id": 59908,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14984,
    "choices": [
      {
        "id": 59896,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vimentin </span></span></span></span></p>"
      },
      {
        "id": 59897,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cytokeratin </span></span></span></span></p>"
      },
      {
        "id": 59898,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Keratin</span></span></span></span></p>"
      },
      {
        "id": 59899,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Collagen</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old man with a history of chronic alcohol abuse presents with abdominal pain and hepatomegaly. Liver biopsy reveals abnormal intracellular inclusions in hepatocytes. Immunohistochemical analysis demonstrates the presence of intermediate filaments. Which protein is the major component of these inclusions?</span></span></p>",
    "unique_key": "Q9543095",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191763,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Cytokeratin </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><strong>Option B:</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mallory bodies </strong>are <strong>visible as eosinophilic cytoplasmic clumps in hepatocytes</strong>. They are <strong>composed of tangled skeins of cytokeratin intermediate filaments </strong>such as <strong>cytokeratin 8 </strong>and <strong>18</strong>, in complex with other proteins such as ubiquitin. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/23/screenshot-2024-04-23-124753.png\" style=\"height:136px; width:300px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cytokeratins </strong>are <strong>intermediate filament proteins </strong>found in <strong>epithelial cells</strong>. The <strong>intracellular inclusions </strong>seen in <strong>hepatocytes</strong>, known as <strong>Mallory bodies</strong>, are composed <strong>primarily of cytokeratin, </strong>particularly <strong>cytokeratin 8 and 18</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Vimentin&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is an <strong>intermediate filament protein </strong>found in <strong>mesenchymal cells </strong>and is not typically associated with hepatocyte inclusions. It&#39;s more commonly related to cells of mesenchymal origin.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Keratins&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are a <strong>broader family </strong>of <strong>fibrous structural proteins</strong>; <strong>cytokeratins </strong>are a <strong>subtype found in epithelial cells</strong>. In the context of liver pathology, it is more accurate to specify cytokeratins as the component of the inclusions.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Collagen&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>structural protein </strong>found in <strong>connective tissues</strong>, such as <strong>tendons and ligaments</strong>, and is not involved in the formation of Mallory bodies within hepatocytes.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mallory bodies</strong>, which are <strong>abnormal intracellular inclusions </strong>found in <strong>hepatocytes</strong>, especially in conditions like <strong>alcoholic liver disease</strong>, are composed predominantly of <strong>cytokeratin intermediate filaments </strong>(CK 8 and 18).</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th 843</span></span></strong></span></span></p>",
    "correct_choice_id": 59897,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14956,
    "choices": [
      {
        "id": 59784,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">G6PD deficiency&nbsp;<i>&nbsp;</i></span></p>"
      },
      {
        "id": 59785,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Hemolytic anemia</span></p>"
      },
      {
        "id": 59786,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Hereditary spherocytosis</span></p>"
      },
      {
        "id": 59787,
        "text": "<p><span style=\"font-size:12.0pt;\">Biliary cirrhosis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient with unconjugated bilirubinemia has increased excretion of urobilinogen in his urine. This can be seen in all of the following conditions, except:</span></p>",
    "unique_key": "Q8264186",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191764,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. D) Biliary cirrhosis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Biliary cirrhosis </strong>primarily <strong>affects the conjugated bilirubin pathway</strong>, and it is associated with <strong>conjugated hyperbilirubinemia</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>G6PD deficiency</strong> can <strong>lead to hemolysis</strong>, resulting in <strong>increased unconjugated bilirubin production</strong>. Therefore, it is associated with increased urobilinogen excretion.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B: Hemolytic anemia,&nbsp;</strong>where <strong>red blood cells </strong>are <strong>destroyed prematurely</strong>, <strong>increase the production </strong>of <strong>unconjugated bilirubin</strong>. This can lead to increased urobilinogen in the urine.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C: Hereditary spherocytosis&nbsp;</strong>is a <strong>hemolytic disorder </strong>characterized by <strong>spherical-shaped red blood cells</strong>, leading to <strong>increased bilirubin production</strong>. It is associated with increased urobilinogen excretion.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Biliary cirrhosis </strong>is associated with <strong>conjugated hyperbilirubinemia</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_EEwYoJr.png\" width=\"1338\" height=\"566\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup> 855</strong></span></p>",
    "correct_choice_id": 59787,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15003,
    "choices": [
      {
        "id": 59972,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute pyelonephritis </span></span></p>"
      },
      {
        "id": 59973,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic pyelonephritis </span></span></p>"
      },
      {
        "id": 59974,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cystitis</span></span></p>"
      },
      {
        "id": 59975,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fanconi syndrome </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28 year young female Katrina present to your OPD with complaints of suprapubic pain, urinary frequency and dysuria. She also passed blood in last voided urine about 30 minutes ago. Her urinanalysis demonstrate the presence of pyuria but no white cell casts. On physical examination, she has suprapubic tenderness on palpation. Which of the following is the likely diagnosis in this patient?</span></span></p>",
    "unique_key": "Q4882370",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191765,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Cystitis </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cystitis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Characterized by symptoms of <strong>lower urinary tract infection</strong>, including <strong>suprapubic pain, dysuria, urinary frequency, and urgency</strong>.<strong> Pyuria and hematuria </strong>are common findings in <strong>cystitis</strong>, but <strong>white cell casts </strong>are typically<strong> absent.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical presentation of the patient in the stem of the question is of cystitis, which is characterized by<strong> pyuria and hematuria </strong>but <strong>absence of white cell casts in the urine</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Acute pyelonephritis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Typically presents with<strong> fever, flank pain, and systemic symptoms </strong>along with <strong>pyuria, leukocytosis, and white cell casts in the urine</strong>. <strong>Suprapubic pain and dysuria </strong>are<strong> less common </strong>in <strong>acute pyelonephritis compared </strong>to cystitis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Chronic pyelonephritis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Usually develops as a result of<strong> recurrent acute pyelonephritis </strong>or <strong>chronic urinary tract obstruction. </strong>It may present with <strong>nonspecific </strong>symptoms such as <strong>fatigue, malaise, and flank pain</strong>, but <strong>suprapubic tenderness and dysuria are less </strong>characteristic.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Fanconi syndrome:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Is a rare <strong>renal tubular disorder </strong>characterized by defects in<strong> proximal tubular function </strong>leading to <strong>renal wasting of electrolytes</strong>, <strong>amino acids, glucose, and low molecular weight proteins</strong>. It typically presents with<strong> metabolic acidosis</strong>, <strong>hypokalemia, hypophosphatemia, glycosuria, and aminoaciduria, </strong>but<strong> not </strong>with symptoms of <strong>urinary tract infection</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> clinical features and diagnostic </strong>findings associated with<strong> cystitis, are lower urinary tract symptoms, pyuria, and hematuria</strong>, but <strong>absence of white cell casts in the urine.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 928) </span></span></em></strong> </span></span></span></span></p>",
    "correct_choice_id": 59974,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14968,
    "choices": [
      {
        "id": 59832,
        "text": "<p><span style=\"font-size:12pt;\">Fusion of foot processes of the glomerular epithelial cells</span></p>"
      },
      {
        "id": 59833,
        "text": "<p><span style=\"font-size:12pt;\">Rarefaction of glomerular basement membrane</span></p>"
      },
      {
        "id": 59834,
        "text": "<p><span style=\"font-size:12pt;\">Deposition of electron dense material in the basement membrane</span></p>"
      },
      {
        "id": 59835,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Thin basement membrane</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 7 year old boy presented with generalized edema. Urine examination revealed marked albuminuria. Serum biochemical examinations showed hypoalbuminemia with hyperlipidemia. Kidney biopsy was undertaken. On light microscopic examination, the kidney appeared normal. Electron microscopic examination is most likely to reveal:</span></p>",
    "unique_key": "Q4088833",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191816,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Fusion of foot process of the glomerular epi\u00adthelial cells</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Fusion of foot processes </strong>of the <strong>glomerular epithelial cells </strong>is characteristic of <strong>minimal change disease</strong>. <strong>Electron microscopy </strong>will reveal<strong> effacement or fusion of the podocyte foot processes </strong>without<strong> immune complex deposition or complement activation.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The<strong> child is presenting </strong>with features likely of <strong>Nephrotic syndrome </strong>whose most frequent cause in <strong>children is minimal change disease </strong>or<strong> lipoid nephrosis</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Light microscopy </strong>there is <strong>no abnormality </strong>whereas on <strong>electron microscopy </strong>there is <strong>fusion of foot pro\u00adcesses of the glomerular epithelial cells </strong>with normal glomeruli.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong> <strong>Rarefaction of the glomerular basement membrane </strong>is <strong>not </strong>a feature of <strong>MCD </strong>but may be seen in other kidney diseases, such as Alport syndrome.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: Deposition of electron-dense material in the basement membrane </strong>is typically observed in diseases such as <strong>membranous nephropathy</strong>, not MCD.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong> A <strong>thin basement membrane </strong>is characteristic of <strong>thin basement membrane disease</strong>, a condition separate from MCD.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The primary finding in <strong>minimal change disease on electron microscopy </strong>is the<strong> effacement or fusion of podocyte foot processes, </strong>which helps in<strong> distinguishing it </strong>from <strong>other glomerular diseases </strong>that may present with<strong> normal findings on light microscopy </strong>but show <strong>specific abnormalities on electron microscopy.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 914)</strong></i></span></p>",
    "correct_choice_id": 59832,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14884,
    "choices": [
      {
        "id": 59496,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lung with pulmonary thromboembolism </span></span></span></p>"
      },
      {
        "id": 59497,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Heart with coronary thrombosis </span></span></span></p>"
      },
      {
        "id": 59498,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liver with hypovolemic shock </span></span></span></p>"
      },
      {
        "id": 59499,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kidney with septic embolus</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">On sectioning of an organ at the time of autopsy, a focal, wedge-shaped firm area is seen accompanied by extensive hemorrhage, with a red appearance. The lesion has a base on the surface of the organ. This finding is typically of:<em> </em></span></span></span></p>",
    "unique_key": "Q7098355",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191817,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Lung with pulmonary thromboembolism </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/29/picture3.jpg\" style=\"height:293px; width:400px\" /></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Image of pulmonary infarct (marked by arrow)</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The morphology is characteristically present as<strong> red (hemorrhagic) infarct. </strong>The red infarcts are seen in<strong> lung, liver and intestine</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>White infarcts </strong>are seen in<strong> brain, spleen, kidney and heart.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lung with pulmonary thromboembolism </strong>is characterized by a <strong>wedge-shaped hemorrhagic infarct</strong>. Due to the <strong>dual blood supply from the bronchial and pulmonary arteries</strong>, these infarcts are typically <strong>red (hemorrhagic).</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Heart with coronary thrombosis </strong>typically results in<strong> pale (white) infarcts </strong>due to the <strong>loss of blood supply to the myocardium</strong>,<strong> unless reperfusion occurs</strong>, which can lead to a<strong> hemorrhagic appearance</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Liver with hypovolemic shock </strong>may not typically present with a<strong> wedge-shaped lesion </strong>but can show<strong> patchy necrosis </strong>due to <strong>global hypoperfusion</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Kidney with septic embolus </strong>can lead to<strong> infarcts </strong>that are generally<strong> pale (white) due to the organ&#39;s end-arterial blood supply</strong>, except in the case of a<strong> dual blood supply or reperfusion, </strong>which can lead to a<strong> hemorrhagic appearance.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pulmonary thromboembolism </strong>is a condition that can present with a <strong>wedge-shaped, hemorrhagic (red) infarct </strong>on organ sectioning during <strong>autopsy, </strong>with the lesion&#39;s<strong> base on the organ surface.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 135)</span></em></strong></span></span></p>",
    "correct_choice_id": 59496,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 8858,
    "choices": [
      {
        "id": 35399,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chlamydia Trachomatis</span></span></span></p>"
      },
      {
        "id": 35400,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mycoplasma Genitalium</span></span></span></p>"
      },
      {
        "id": 35401,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Trichomonas Vaginalis</span></span></span></p>"
      },
      {
        "id": 35402,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Neisseria Gonorrhoeae</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 26-year-old man complains of burning pain when urinating. He reluctantly acknowledges that four days ago, he engaged in unprotected sexual activity. The following examination findings are seen. Which of the following organisms is most likely to be the cause?<br />\r\n<br />\r\n<img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/17/picture5_0aUXwuz.jpg\" style=\"height:283px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>",
    "unique_key": "Q6378290",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191818,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Neisseria Gonorrhoeae</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span style=\"font-size:12.0pt\">D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Neisseria gonorrhoeae</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The patient&#39;s symptoms, which appeared <strong>four days</strong> after <strong>unprotected sex</strong>, are consistent with <strong>urethritis</strong> brought on by <strong>Neisseria gonorrhoeae</strong>, whose incubation period is <strong>one to five days.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Male gonococcal infection most frequently manifests as <strong>acute urethritis</strong> with <strong>dysuria</strong> and <strong>profuse purulent discharge</strong>. Depending on the nature of the sexual contact, pharyngeal and rectal infections can also happen.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">However, the <strong>urethra</strong>, <strong>rectum</strong>, and <strong>pharynx</strong> may also be affected. In women, the <strong>cervix</strong> is the <strong>primary site</strong> of infection.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Excessive vaginal discharge</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">, <strong>dysuria</strong>, <strong>profound dyspareunia</strong>, <strong>postcoital bleeding</strong>, and <strong>intermenstrual bleeding</strong> are among the symptoms.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Non-gonococcal urethritis (NGU) is most frequently brought on by Chlamydia, which has a 1&ndash;3-week incubation period.<br />\r\n\tTypically, only dysuria is present, but mucopurulent discharge can also happen. NGU can also be brought on by Mycoplasma genitalium and Trichomonas vaginalis.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Chlamydia trachomatis:</strong></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is also a common cause of urethritis, but it typically causes a less pronounced or even <strong>asymptomatic presentation</strong> compared to gonorrhea.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.&nbsp;</span></strong><span style=\"font-size:12.0pt\"><strong>Mycoplasma genitalium:</strong></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is another cause of urethritis but is less common than gonorrhea and chlamydia and often causes milder symptoms.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.&nbsp;</span></strong><span style=\"font-size:12.0pt\"><strong>Trichomonas vaginalis:</strong></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This causes <strong>trichomoniasis</strong> which typically presents with a <strong>frothy discharge</strong> and is more commonly <strong>symptomatic in females</strong> than males.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/17/feature2.jpg\" style=\"height:1167px; width:1000px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><u><span style=\"font-size:12.0pt\">:</span></u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">When a male patient presents with <strong>purulent urethral discharge</strong> and reports recent <strong>unprotected sexual activity</strong>, the most likely diagnosis is <strong>gonococcal urethritis</strong>, caused by <strong>Neisseria gonorrhoeae</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Identification is typically confirmed through <strong>culture of the discharge</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-size:12.0pt\">Rook&#39;s Textbook of Dermatology 9th edition Chapter 30, Page no 30.3</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Harrison&#39;s Principles of Internal Medicine - 19th Edition Page no 1005</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Online Resource</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><a href=\"https://www.uptodate.com/contents/urethritis-in-adult-men?search=mycoplasma%20genitalium&amp;source=search_result&amp;selectedTitle=3~31&amp;usage_type=default&amp;display_rank=3#H1458429\" style=\"color:#0563c1; text-decoration:underline\"><strong><span style=\"font-size:12.0pt\">https://www.uptodate.com/contents/urethritis-in-adult-men?search=mycoplasma%20genitalium&amp;source=search_result&amp;selectedTitle=3~31&amp;usage_type=default&amp;display_rank=3#H1458429</span></strong></a></span></span></p>\r\n\r\n<p>&nbsp;</p>",
    "correct_choice_id": 35402,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 35547,
    "choices": [
      {
        "id": 141995,
        "text": "<p><span style=\"font-size:12.0pt;\">1-b, 2-c, 3-a</span></p>"
      },
      {
        "id": 141996,
        "text": "<p><span style=\"font-size:12.0pt;\">1-b, 2-d, 3-a</span></p>"
      },
      {
        "id": 141997,
        "text": "<p><span style=\"font-size:12.0pt;\">1-d, 2-c, 3-b</span></p>"
      },
      {
        "id": 141998,
        "text": "<p><span style=\"font-size:12.0pt;\">1-d, 2-c, 3-a</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Match the Diseases in Colum A with STI Kit colour in Colum B:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/17/picture17_kODE4Go.jpg\" alt=\"\" width=\"500\" height=\"159\"></span></p>",
    "unique_key": "Q6150636",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191819,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. A) 1-b, 2-c, 3-a</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A: </strong>1-b, 2-c, 3-a</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The correct match between the Diseases in Colum A with STI Kit colour in Colum B</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/17/picture18_h1o0TP0.jpg\" alt=\"\" width=\"1000\" height=\"273\"></span></p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp;&nbsp;</span></p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>1. Urethritis - b Grey</strong> \u2013</span><br>&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Urethritis,&nbsp;</strong>which is inflammation of the urethra, typically presents with <strong>dysuria and discharge</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The <strong>grey</strong> color kit is often used for treatment protocols of urethritis, which includes antibiotics targeting common causative organisms like <strong>Neisseria gonorrhoeae and Chlamydia trachomatis</strong>.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>2. Non-herpetic genital ulcers - c White / Blue</strong> \u2013</span><br>&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Genital ulcers that are not caused by herpes simplex virus may be due to diseases like <strong>syphilis or chancroid</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The treatment for these conditions often involves antibiotics like <strong>penicillin or azithromycin</strong>, which may be represented by a <strong>white/blue colored</strong> kit.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>3. Vaginal discharge - a Green</strong> \u2013</span><br>&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The green kit is commonly associated with the treatment of vaginal discharge syndromes, which can be caused by <strong>bacterial vaginosis, trichomoniasis, or candidiasis</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Treatments usually include <strong>metronidazole</strong>, which are effective against these conditions.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>4. Pelvic inflammatory disease - d Yellow</strong> \u2013</span><br>&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The yellow kit is for managing pelvic inflammatory disease (PID), which requires <strong>broad-spectrum antibiotics</strong> to cover likely pathogens, including sexually transmitted ones.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Details of color coded STI/RTI kits -</strong></span></p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_OqUyUrb.png\" width=\"518\" height=\"522\"></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref:</u></strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Online resource:</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>National Technical Guidelines on Sexually Transmitted Infections and Reproductive Tract Infections 2024</strong></span></p><p><a href=\"https://naco.gov.in/sites/default/files/National%20Technical%20Guidelines%20on%20STI%20and%20RTI_Final.pdf\"><span style=\"font-size:12.0pt;\"><strong>https://naco.gov.in/sites/default/files/National%20Technical%20Guidelines%20on%20STI%20and%20RTI_Final.pdf</strong></span></a><span style=\"font-size:12.0pt;\"><strong> &nbsp;page 64</strong></span></p>",
    "correct_choice_id": 141995,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 8870,
    "choices": [
      {
        "id": 35447,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is triggered by lipoproteins</span></span></span></p>"
      },
      {
        "id": 35448,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Penicillin cannot be used in future</span></span></span></p>"
      },
      {
        "id": 35449,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fever usually comes down within 8 hours</span></span></span></p>"
      },
      {
        "id": 35450,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">D Jarisch-Herxheimer reaction occurs within 24 hours of penicillin therapy</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After 14 hours of receiving Injection Penicillin for her early latent syphilis, a 35-year-old woman suddenly develops a high-grade fever, myalgia, and bone pain. Which of the following statements is FALSE with respect to her condition?</span></span></span></p>",
    "unique_key": "Q3638898",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191820,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Penicillin cannot be used in future</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> B: Penicillin cannot be used in future </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The <strong>Jarisch-Herxheimer</strong> reaction is a temporary reaction to <strong>antibiotic therapy</strong> for syphilis, characterized by <strong>fever, myalgia, and bone pain</strong>, and is not a contraindication to future penicillin use.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A <strong>febrile reaction</strong> occurring <strong>within 24 hours</strong> of penicillin therapy for syphilis is suggestive of <strong>Jarisch-Herxheimer&#39;s reaction</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Jarisch-Herxheimer reaction is <strong>self-limiting</strong> and is due to <strong>lipoprotein release</strong> from the <strong>dying treponemes</strong>, which trigger <strong>cytokine release. </strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The patient presents with <strong>flu-like symptoms</strong> and <strong>exacerbation</strong> of <strong>skin lesions</strong>. <strong>Fever</strong> rarely lasts <strong>more than 8 hours</strong>. Symptoms may be controlled by <strong>antipyretics</strong>. It is not a contraindication for penicillin use in the future.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Penicillin allergy is a contraindication for further use. JH reactions must be differentiated from <strong>penicillin allergy</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Constitutional Symptoms such as Fever, Joint Pain, Hypotension along with Worsening of Skin Lesions. Treatment : Symptomatic</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Allergic reactions</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> can be early or late as follows:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Early type- anaphylaxis within 1 hour of the first dose.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Late type- rash after several doses of penicillin.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In <strong>Jarisch-Herxheimer&#39;s</strong> reaction, <strong>Corticosteroids</strong> are only indicated in <strong>pregnant women</strong> and patients with <strong>neurosyphilis</strong> in whom the reaction can be more <strong>serious and life-threatening</strong> sequelae.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The <strong>Jarisch-Herxheimer</strong> reaction is a temporary reaction to <strong>antibiotic therapy</strong> for syphilis, characterized by <strong>fever, myalgia, and bone pain</strong>, and is not a contraindication to future penicillin use.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Rook&#39;s Textbook of Dermatology 9th edition</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chapter 29, Page nos 29.26</span></strong></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fitzpatrick&rsquo;s dermatology 9th edition page 3167</span></span></strong></p>",
    "correct_choice_id": 35448,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 8873,
    "choices": [
      {
        "id": 35459,
        "text": "<p><span style=\"font-size:12pt;\">Green kit</span></p>"
      },
      {
        "id": 35460,
        "text": "<p><span style=\"font-size:12pt;\">Red kit</span></p>"
      },
      {
        "id": 35461,
        "text": "<p><span style=\"font-size:12pt;\">Blue kit</span></p>"
      },
      {
        "id": 35462,
        "text": "<p><span style=\"font-size:12.0pt;\">D White kit</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 25-year-old woman has come down with painful lesions as shown below. She tells you that vesicles were present 5 days back over the same site and says that she is allergic to penicillin. On examination, she has bilateral tender lymphadenopathy. Which kit will you use to treat her?</span><br><br><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/19/picture10_ox0D7x9.jpg\" alt=\"\" width=\"300\" height=\"402\"></p>",
    "unique_key": "Q3755408",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191821,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;<strong>B) Red kit</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option&nbsp;B: Red kit</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The treatment of <strong>Genital Herpes</strong> involves antiviral therapy, which is typically provided in the <strong>red kit</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">It contains <strong>acyclovir 400 mg tablets</strong> to be taken <strong>TDS for 7 days</strong>, which is effective against the <strong>herpes simplex virus.</strong></span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The clinical picture of <strong>multiple, grouped painful ulcers</strong> with <strong>tender lymphadenopathy</strong> in this patient points to a diagnosis of <strong>herpes genitalis</strong> infection by <strong>HSV-2.</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">It is treated with a <strong>red kit</strong>. In herpetic genital ulcer disease, treatment of <strong>asymptomatic partners</strong> is not required.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The <strong>red kit or kit 5</strong> is meant for genital ulcer disease - herpetic. It contains <strong>acyclovir 400 mg tablets</strong> to be taken <strong>TDS for 7 days</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Chancroid,</strong> which manifests as numerous, tender soft, painful ulcers, &amp; bilateral lymphadenopathy is a close differential diagnosis.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Chancroid, on the other hand, <strong>lacks vesicles</strong> and has <strong>deeper ulcers</strong> with ragged, <strong>undermined edges.</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Only when the patient presents with the primary chancre of syphilis is the patient's history of <strong>penicillin drug allerg</strong>y relevant.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">They would need to be treated with a <strong>blue kit</strong> in this situation rather than a white kit.</span></p></li></ul><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_jC3Sc3Y.png\" width=\"518\" height=\"522\"></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective</u></strong><u>:</u></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The treatment of <strong>Genital Herpes</strong> involves antiviral therapy, which is typically provided in the <strong>red kit</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">It contains <strong>acyclovir 400 mg tablets</strong> to be taken <strong>TDS for 7 days</strong>, which is effective against the <strong>herpes simplex virus.</strong></span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref:</u>&nbsp; National Health Programs of India&nbsp;</strong></span><a href=\"http://naco.gov.in/sites/default/files/Syndromic%20Poster_REDUCED.pdf\"><span style=\"font-size:12pt;\"><strong><u>http://naco.gov.in/sites/default/files/Syndromic%20Poster_REDUCED.pdf</u></strong></span></a><span style=\"font-size:12pt;\"><strong>&nbsp; Harrison's Principles Of Internal Medicine - 19th Edition&nbsp;Page no 880&nbsp;</strong></span></p>",
    "correct_choice_id": 35460,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16920,
    "choices": [
      {
        "id": 67640,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Borderline Tuberculoid is the most common type of Leprosy in India</span></span></span></p>"
      },
      {
        "id": 67641,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Borderline Borderline is the most unstable form of Leprosy</span></span></span></p>"
      },
      {
        "id": 67642,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Earliest Sign of Leprosy is Loss of Temperature</span></span></span></p>"
      },
      {
        "id": 67643,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Facial Nerve is the most common nerve involved in Leprosy</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following are correct statements regarding leprosy EXCEPT</span></span></p>",
    "unique_key": "Q2761729",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191822,
    "difficulty_level": "difficult",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D) Facial&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nerve is the most common nerve involved in Leprosy</span></strong><strong><span style=\"font-size:12.0pt\">.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ulnar nerve&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">is the <strong>most commonly</strong> affected nerve in leprosy.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nerve&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">involvement in<strong> leprosy</strong></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:96px; text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ulnar </span></strong><span style=\"font-size:12.0pt\">&gt; Posterior tibial &gt; Median &gt; Lateral popliteal &gt; Facial</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Borderline Tuberculoid</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is the most common type of leprosy in India.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Borderline Tuberculoid presents as a <strong>hypopigmented</strong> skin lesion with <strong>pseudopodia </strong>&amp; <strong>satellite lesions</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/2.jpg\" style=\"height:494px; width:500px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Spectrum&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">of leprosy in India in <strong>decreasing</strong> order of <strong>prevalence.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:96px; text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Borderline Tuberculoid </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&gt; <strong>Borderline Lepromatous </strong>&gt; Lepromatous Leprosy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B.&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Borderline Borderline</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is the most unstable form of leprosy:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Presenting with <strong>punched out</strong> anesthetic lesions, which have <strong>Geographical </strong>or <strong>Map like</strong> appearance. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inverted saucer &amp; <strong>punched out</strong> lesions are characteristic of <strong>Borderline Borderline leprosy.</strong> </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is rarely seen as it <strong>rapidly</strong> upgrades <strong>towards tuberculoid</strong> or <strong>downgrades</strong> towards <strong>lepromatous pole</strong>, based on <strong>immune status </strong>of the individual.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/3.jpg\" style=\"height:335px; width:500px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/picture1_Qrhvqpl.jpg\" style=\"height:316px; width:600px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pure Neuritic&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">leprosy (PNL)is <strong>not</strong> included in the <strong>Ridley Jopling</strong> classification. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mononeuritis&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">is the most common form of presentation of <strong>PNL.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nerve biopsy&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">is the <strong>gold standard</strong> method for the diagnosis of <strong>PNL.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Earliest sign&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">of leprosy is <strong>loss of temperature</strong>, seen over he <strong>hands</strong> &amp; <strong>feet</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sensations lost</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> in the following order:</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:40px; text-align:justify\"><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Temperature </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&gt; Fine Touch &gt; Pain &gt; Deep Touch or Pressure</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ulnar Nerve</strong> is the <strong>most affected nerve </strong>in<strong> Leprosy</strong>, not the facial nerve. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Early signs of leprosy include <strong>Loss of Temperature Sensation, </strong>and<strong> Borderline Borderline Leprosy </strong>is the most<strong> immunologically unstable form</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Journal: </span></strong><a href=\"https://ijdvl.com/current-scenario-of-leprosy-at-tertiary-care-level-hospital-of-rural-central-india/\" style=\"color:#0563c1; text-decoration:underline\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">https://ijdvl.com/current-scenario-of-leprosy-at-tertiary-care-level-hospital-of-rural-central-india/</span></strong></a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318064/\" style=\"color:#0563c1; text-decoration:underline\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318064/</span></strong></a>,&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Harrison&rsquo;s Principles of Internal Medicine &ndash; 19<sup>th</sup> Edition Page 1124,.&nbsp;</span></strong></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Harrison&rsquo;s Principles of Internal Medicine 20<sup>th</sup> Edition Chapter 174 Leprosy,&nbsp;</span></strong></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Andrew&rsquo;s Diseases of the Skin: Clinical Dermatology &ndash; 12<sup>th</sup> Edition Page No 336,&nbsp;</span></strong></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rooks Textbook of Dermatology 9th Edition Page 28.10 &ndash; 28.11</span></strong></span></span></p>",
    "correct_choice_id": 67643,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14867,
    "choices": [
      {
        "id": 59428,
        "text": "<p><span style=\"font-size:12.0pt;\">Silicosis</span></p>"
      },
      {
        "id": 59429,
        "text": "<p><span style=\"font-size:12.0pt;\">Byssinosis</span></p>"
      },
      {
        "id": 59430,
        "text": "<p><span style=\"font-size:12.0pt;\">Asbestosis</span></p>"
      },
      {
        "id": 59431,
        "text": "<p><span style=\"font-size:12.0pt;\">Bagassosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Ferruginous bodies are seen in:</span></p>",
    "unique_key": "Q4465712",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191823,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Asbestosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/29/picture2.jpg\" alt=\"\" width=\"1000\" height=\"449\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Asbestosis:</strong> Asbestosis is a<strong> lung disease </strong>caused by <strong>the inhalation of asbestos fibers</strong>.<strong> Ferruginous bodies </strong>are specifically associated with <strong>asbestos exposure</strong>. These bodies are formed when <strong>iron-containing proteins coat asbestos fibers </strong>in the lungs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A:&nbsp;Silicosis:</strong> Silicosis is a<strong> lung disease </strong>caused by the<strong> inhalation of crystalline silica dust.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B:&nbsp;Byssinosis:</strong> Byssinosis, also known as <strong>\"brown lung disease\" or \"Monday fever</strong>,\" is an occupational lung disease caused by the inhalation of<strong> cotton, flax, or hemp dust.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D:&nbsp;Bagassosis:&nbsp;</strong>Bagassosis is a type of<strong> pneumoconiosis </strong>caused by the inhalation of dust from<strong> moldy sugarcane.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ferruginous bodies </strong>are <strong>not typically </strong>associated with<strong> silicosis, byssinosis and bagassosis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 701)</strong></i></span></p>",
    "correct_choice_id": 59430,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14850,
    "choices": [
      {
        "id": 59360,
        "text": "<p><span style=\"font-size:12.0pt;\">Caseation</span></p>"
      },
      {
        "id": 59361,
        "text": "<p><span style=\"font-size:12pt;\">Recruitment of lymphocytes</span></p>"
      },
      {
        "id": 59362,
        "text": "<p><span style=\"font-size:12pt;\">Formation of giant cells (Langhans)</span></p>"
      },
      {
        "id": 59363,
        "text": "<p><span style=\"font-size:12pt;\">Granuloma formation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A 35-year-old woman presents with a persistent cough, night sweats, and unintentional weight loss. Chest X-ray reveals an infiltrate in the upper lobe of the right lung. Which of the following is the earliest feature of tuberculosis?</span></p>",
    "unique_key": "Q9112635",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191824,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B. Recruitment of lymphocytes</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Recruitment of lymphocytes:</strong> The<strong> initial immune </strong>response to<strong> M. tuberculosis </strong>includes <strong>recruitment of lymphocytes </strong>to the site of <strong>infection.</strong> This is part of the <strong>early host defense</strong>, which precedes<strong> granuloma formation</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A: Caseation:</strong> Caseation, a form of <strong>necrosis typical of tuberculosis</strong>, is a later feature that occurs after the <strong>immune system </strong>has attempted to <strong>contain the infection</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C: Formation of giant cells (Langhans):</strong> Giant cell formation is part of the<strong> granuloma </strong>response and occurs after <strong>lymphocyte recruitment</strong>, as part of the body's attempt to wall off and contain the infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D: Granuloma formation:</strong> Granuloma formation is a<strong> hallmark of the body's defense against tuberculosis </strong>but is <strong>not </strong>the <strong>earliest</strong> event. It occurs after<strong> lymphocytes and macrophages </strong>have been recruited to the site of infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Recruitment of lymphocytes </strong>is the earliest feature in the<strong> immune response </strong>to <strong>M. tuberculosis infection</strong>. Following<strong> infection, lymphocytes are recruited, </strong>leading to the<strong> activation of macrophages and subsequent granuloma formation</strong>.</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 378)</strong></i></span></p>",
    "correct_choice_id": 59361,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14839,
    "choices": [
      {
        "id": 59316,
        "text": "<p><span style=\"font-size:12pt;\">Presence of interstitial inflammation</span></p>"
      },
      {
        "id": 59317,
        "text": "<p><span style=\"font-size:12pt;\">Predominance of alveolar exudate</span></p>"
      },
      {
        "id": 59318,
        "text": "<p><span style=\"font-size:12pt;\">Bronchiolitis</span></p>"
      },
      {
        "id": 59319,
        "text": "<p><span style=\"font-size:12pt;\">Multinucleate giant cells in the bronchiolar wall</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">All of the following features are seen in the viral pneumonia except:</span></p>",
    "unique_key": "Q6591704",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191825,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B. Predominance of alveolar exudate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Predominance of alveolar exudate:</strong> Alveolar exudate is characteristic of <strong>bacterial pneumonia</strong>, where the<strong> alveoli are filled with fluid and inflammatory cells</strong>. This feature is <strong>less common in viral pneumonia, </strong>which tends to involve the<strong> interstitium and bronchioles more </strong>than the <strong>alveoli.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Presence of interstitial inflammation:</strong> This is a<strong> common feature </strong>in <strong>viral pneumonia</strong>, where the infection leads to <strong>inflammation predominantly </strong>in the <strong>tissue and space around the air sacs of the lungs</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Bronchiolitis:</strong> Bronchiolitis, which is<strong> inflammation of the small airways or bronchioles, </strong>is commonly seen in<strong> viral pneumonia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Multinucleate giant cells in the bronchiolar wall:</strong> The presence of multinucleate giant cells is a<strong> histopathological feature </strong>sometimes seen in<strong> viral infections, </strong>reflecting the body's response to<strong> viral replication within cells</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The<strong> predominance of alveolar exudate </strong>is<strong> not </strong>a feature commonly seen in<strong> viral pneumonia; </strong>instead, it is a <strong>hallmark of bacterial pneumonia</strong>. <strong>Viral pneumonia </strong>typically presents with <strong>interstitial inflammation, bronchiolitis</strong>, and can have <strong>multinucleate giant cells </strong>in the bronchiolar wall.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Histopathological Features of Viral Pneumonia:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Luhw4oK.png\" width=\"1281\" height=\"502\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 708)</strong></span></p>",
    "correct_choice_id": 59317,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14761,
    "choices": [
      {
        "id": 59005,
        "text": "<p><span style=\"font-size:12pt;\">1\u20132 days</span></p>"
      },
      {
        "id": 59006,
        "text": "<p><span style=\"font-size:12pt;\">3 weeks</span></p>"
      },
      {
        "id": 59007,
        "text": "<p><span style=\"font-size:12pt;\">6 hours</span></p>"
      },
      {
        "id": 59008,
        "text": "<p><span style=\"font-size:12pt;\">1 week</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The following is the hematoxylin and eosin stained section from the heart of a patient after myocardial infarction. What can you say about the age of the infarction?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/22/picture5.jpg\" alt=\"\" width=\"300\" height=\"198\"></span></p>",
    "unique_key": "Q6986173",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191826,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) 6 hours</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Presence of a coagulative necrotic pattern </strong>along with <strong>widened space between dead fibers </strong>and <i>wavy fiber </i>appearance sug\u00adgests this to a pattern of<strong> injury taking place around 6 hours.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The described appearance of <strong>coagulative necrosis</strong> with<strong> widened spaces between dead fibers and a wavy fiber appearance </strong>is characteristic of the changes seen approximately<strong> 6 hours after an infarction</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong> <strong>At 1\u20132 days post-infarction, </strong>one would expect to see <strong>more infiltration by inflammatory cells</strong>,<strong> particularly neutrophils, and ongoing coagulative necrosis </strong>with<strong> loss of nuclei and striations, </strong>which is <strong>not </strong>the primary finding described.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong> <strong>By 3 weeks, </strong>the <strong>necrotic area </strong>would likely be<strong> undergoing repair</strong>, with<strong> granulation tissue and new collagen deposition</strong>, which is<strong> not </strong>indicated by the <strong>presence of coagulative necrosis and wavy fibers.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong> <strong>At 1 week</strong>, one would expect to see the <strong>beginnings of granulation tissue formation</strong>, which is<strong> not </strong>consistent with the<strong> early necrotic pattern </strong>described in the <strong>vignette.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A <strong>coagulative necrotic pattern </strong>with <strong>widened spaces between dead fibers and wavy fiber </strong>appearance on a histological section of <strong>myocardium </strong>is suggestive of a <strong>myocardial injury </strong>that occurred around <strong>6 hours prior</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">Histological Features of MI by Time Frame:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_8PpfDsx.png\" width=\"1489\" height=\"439\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 548)</strong></span></p>",
    "correct_choice_id": 59007,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14742,
    "choices": [
      {
        "id": 58929,
        "text": "<p><span style=\"font-size:12pt;\">C- reactive protein</span></p>"
      },
      {
        "id": 58930,
        "text": "<p><span style=\"font-size:12pt;\">Anti- proteinase 3</span></p>"
      },
      {
        "id": 58931,
        "text": "<p><span style=\"font-size:12pt;\">Cryoglobulin</span></p>"
      },
      {
        "id": 58932,
        "text": "<p><span style=\"font-size:12pt;\">Platelet count</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which laboratory test parameter can indicate the highest relative risk for developing atherosclerosis?</span></p>",
    "unique_key": "Q3430486",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191827,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) C- reactive protein</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>C-reactive protein (CRP)</strong> is an <strong>inflammatory marker </strong>that when<strong> elevated</strong>, indicates<strong> endothelial cell activation </strong>and is associated with the development of<strong> atherosclerosis and cardiovascular risk.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>C- reactive protein (CRP) </strong>is an <strong>acute phase reactant </strong>that causes <strong>endothelial cell activation, </strong>promote <strong>thrombosis and increases leukocyte adhesiveness </strong>in developing <strong>atheromas.</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">It is an<strong> independent predictor </strong>of CV risk.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: Anti-proteinase 3 (PR3)</strong> is an <strong>antibody </strong>associated with<strong> vasculitis</strong>, specifically <strong>granulomatosis with polyangiitis</strong>, and is <strong>not </strong>a direct marker for <strong>atherosclerosis risk.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: Cryoglobulins</strong> are<strong> immunoglobulins </strong>that precipitate in the <strong>cold </strong>and are associated with <strong>cryoglobulinemic vasculitis </strong>but are not direct indicators of atherosclerotic risk.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: Platelet count</strong> can reflect<strong> thrombotic risk </strong>but is<strong> not an independent predictor of atherosclerosis or cardiovascular disease</strong> like<strong> CRP.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>CRP </strong>is an <strong>acute-phase reactant </strong>that, when <strong>elevated</strong>, suggests <strong>systemic inflammation </strong>and is an <strong>independent risk factor </strong>for <strong>atherosclerosis and subsequent cardiovascular events</strong>.</span></p>",
    "correct_choice_id": 58929,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14706,
    "choices": [
      {
        "id": 58785,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Temporal arteritis </span></span></p>"
      },
      {
        "id": 58786,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wegener&rsquo;s granulomatosis </span></span></p>"
      },
      {
        "id": 58787,
        "text": "<p><span dir=\"ltr\" lang=\"DE\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polyarteritis nodosa </span></span></p>"
      },
      {
        "id": 58788,
        "text": "<p><span dir=\"ltr\" lang=\"DE\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Henoch\u2011Sch&ouml;nlein purpura </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which is associated with vasculitis of medium size vessels? </span></span></span></p>",
    "unique_key": "Q7500241",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191828,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Polyarteritis nodosa </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Polyarteritis nodosa</strong> (PAN) is associated with <strong>vasculitis of medium-sized vessels.</strong> It is a <strong>systemic necrotizing vasculitis </strong>that affects <strong>medium-sized arteries,</strong> leading to <strong>inflammation, damage,</strong> and potential <strong>organ dysfunction.</strong> <strong>PAN</strong> can involve <strong>various organs</strong>, including the <strong>kidneys, heart, gastrointestinal tract,</strong> and <strong>nerves</strong>, due to the widespread nature of <strong>medium-sized artery inflammation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Temporal arteritis,</strong> also known as <strong>giant cell arteritis,</strong> primarily involves <strong>large and medium-sized arteries.</strong> It commonly affects the temporal arteries.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Wegener&#39;s granulomatosis</strong> (now known as Granulomatosis with Polyangiitis or GPA) involves <strong>small to medium-sized vessels,</strong> affecting the <strong>respiratory tract</strong> (nose, sinuses, and lungs) and sometimes the <strong>kidneys.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Henoch-Sch&ouml;nlein purpura</strong> typically involves <strong>small vessels,</strong> such as <strong>capillaries and arterioles.</strong> It is characterized by <strong>immune-mediated inflammation of blood vessels</strong>, leading to symptoms like <strong>palpable purpura</strong>, <strong>joint pain, and abdominal pain</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Polyarteritis nodosa </strong>(PAN) is associated with <strong>vasculitis of medium-sized vessels </strong>associated with <strong>hepatitis B infection.</strong>&nbsp; </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 513)</span></em></strong></span></span></p>",
    "correct_choice_id": 58787,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14684,
    "choices": [
      {
        "id": 58697,
        "text": "<p><span style=\"font-size:12pt;\">Henoch-Schonlein Purpura</span></p>"
      },
      {
        "id": 58698,
        "text": "<p><span style=\"font-size:12pt;\">Wegner\u2019s granulomatosis</span></p>"
      },
      {
        "id": 58699,
        "text": "<p><span style=\"font-size:12pt;\">Giant cell Vasculitis</span></p>"
      },
      {
        "id": 58700,
        "text": "<p><span style=\"font-size:12pt;\">Kawasaki\u2019s disease</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 5\u2011year\u2011old child presents with perivascular IgA deposition and neutrophilic collection. There is erythematous rash on the lower limbs and non-blanching purpura. The likely diagnosis in the child is:</span></p>",
    "unique_key": "Q4817766",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191829,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Henoch-Schonlein Purpura</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>HSP </strong>is a <strong>small-vessel vasculitis </strong>that commonly occurs in <strong>children</strong>. It is characterized by <strong>perivascular IgA deposition</strong>,<strong> neutrophilic infiltration, </strong>and involvement of<strong> small blood vessels</strong>. Skin manifestations often include a<strong> rash on the lower limbs</strong>, which may be <strong>erythematous and have non-blanching purpura.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: Wegener's Granulomatosis: </strong>Wegener's granulomatosis is a form of <strong>granulomatosis with polyangiitis (GPA</strong>), which primarily affects the<strong> upper and lower respiratory tracts and kidneys</strong>. It is not typically associated with IgA deposition.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: Giant Cell Vasculitis: </strong>Giant cell vasculitis, such as <strong>giant cell arteritis</strong>, usually occurs in <strong>older </strong>individuals and involves<strong> large and medium-sized arteries</strong>. It is<strong> not </strong>commonly seen in <strong>children </strong>and does not present with the characteristic skin findings described.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: Kawasaki's Disease: </strong>Kawasaki's disease is a<strong> vasculitis </strong>that affects <strong>medium-sized vessels</strong>, particularly the <strong>coronary arteries. </strong>While it can present with a<strong> rash</strong>, it is <strong>not </strong>associated with <strong>perivascular IgA deposition</strong>, which is a characteristic feature of <strong>HSP.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Henoch-Sch\u00f6nlein purpura (HSP) </strong>is a<strong> small-vessel vasculitis </strong>that most commonly occurs in<strong> children </strong>and is characterized by a<strong> tetrad of palpable purpura, abdominal pain, arthralgia, and renal involvement. </strong>It is often preceded by an <strong>upper respiratory tract infection </strong>and is associated with<strong> IgA immune complex deposition in the affected vessels.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 561)</strong></i></span></p>",
    "correct_choice_id": 58697,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14819,
    "choices": [
      {
        "id": 59237,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Low fat diet</span></p>"
      },
      {
        "id": 59238,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">High protein diet</span></p>"
      },
      {
        "id": 59239,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Low gluten diet</span></p>"
      },
      {
        "id": 59240,
        "text": "<p><span style=\"font-size:12pt;\">Low calorie diet</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 12-year-old male presented with bloating of abdomen and steatorrhea. His HLA DQ2 was positive. Which of the following is the diet modification helping in the improvement of the condition of the patient?</span></p>",
    "unique_key": "Q4194383",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191830,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Low gluten diet</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Celiac disease </strong>is treated by <strong>removing gluten from the diet</strong>, which is found in <strong>wheat, barley, rye, and their derivatives</strong>. This prevents the<strong> immune response that damages the small intestine</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option A.</strong>&nbsp;<strong>A low-fat diet</strong> can be recommended for specific conditions such as <strong>pancreatitis or gallbladder disease, </strong>but <strong>celiac disease primarily </strong>requires the <strong>elimination of gluten from the diet</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option B.&nbsp;While a balanced diet&nbsp;</strong>is important, the focus for<strong> treating celiac disease is on removing gluten</strong>, which is the<strong> trigger for the autoimmune response </strong>causing the symptoms.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option D.</strong>&nbsp;<strong>Reducing calorie</strong> intake<strong> does not </strong>have a role in the management of<strong> celiac disease </strong>unless there are<strong> concurrent issues </strong>with <strong>obesity or metabolic syndrome.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The <strong>most effective dietary </strong>modification for a patient with<strong> celiac disease</strong>, suggested by the symptoms of<strong> malabsorption and a positive HLA DQ2, is a gluten-free diet.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup> /e p784</strong></span></p>",
    "correct_choice_id": 59239,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14784,
    "choices": [
      {
        "id": 59097,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Crohn&rsquo;s disease </span></span></span></p>"
      },
      {
        "id": 59098,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ulcerative colitis </span></span></span></p>"
      },
      {
        "id": 59099,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amoebiasis </span></span></span></p>"
      },
      {
        "id": 59100,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Giardiasis</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Granulomatous inflammation is found in: </span></span></span></p>",
    "unique_key": "Q1741769",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191831,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Crohn&rsquo;s disease </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option A: </span></span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Characterized by<strong> granulomatous inflammation</strong>, which is one of the key <strong>histopathological features </strong>that can involve <strong>any segment of the GI tract</strong>. It is known for<strong> transmural inflammation, skip lesions, and granuloma formation.</strong></span></span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Explanation:</span></span></span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#0d0d0d\"><strong>Option B.</strong>&nbsp;</span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"><strong>Ulcerative colitis</strong> is a <strong>chronic inflammatory </strong>condition that affects the<strong> colonic mucosa with continuous lesions</strong>, but without the granulomas typical of Crohn&#39;s disease.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#0d0d0d\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"><strong>Amoebiasis</strong>, caused by <strong>Entamoeba histolytica</strong>, can result in <strong>ulcerative lesions </strong>within the<strong> GI tract </strong>but does not produce <strong>granulomatous inflammation.</strong></span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#0d0d0d\"><strong>Option D.</strong>&nbsp;</span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"><strong>Giardiasis</strong>, caused by the protozoan<strong> Giardia lamblia</strong>, typically results in <strong>malabsorption and diarrhea after </strong>affecting the <strong>small intestine</strong>, but without granulomas.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Granulomatous inflammation </strong>is a <strong>specific histopathological finding </strong>that supports the diagnosis of <strong>Crohn&#39;s disease </strong>and is not typically found in <strong>ulcerative colitis, amoebiasis, or giardiasis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 801</span></strong></span></span></p>",
    "correct_choice_id": 59097,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14774,
    "choices": [
      {
        "id": 59057,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Rectum</span></p>"
      },
      {
        "id": 59058,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Colon</span></p>"
      },
      {
        "id": 59059,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Esophagus</span></p>"
      },
      {
        "id": 59060,
        "text": "<p><span style=\"font-size:12pt;\">Jejunum</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In Peutz-Jeghers syndrome, polyps are mainly seen in:</span></p>",
    "unique_key": "Q8662399",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191832,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. D) Jejunum</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The <strong>polyps of Peutz-Jeghers syndrome (PJS) </strong>are <strong>most com\u00admon in the small intestine especially jejunum</strong>, although they may occur in the stomach and colon, and, with much lower frequency, in the bladder and lungs.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The<strong> jejunum is the most frequently </strong>affected site, and patients with <strong>Peutz-Jeghers syndrome </strong>often develop polyps here that can cause complications like <strong>intussusception.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A.&nbsp;Rectal involvement </strong>is possible in<strong> Peutz-Jeghers syndrome</strong>, but it is <strong>not the primary site of polyp </strong>development.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B.&nbsp;</strong>The <strong>colon can be involved</strong>, but the <strong>small intestine</strong>, particularly the <strong>jejunum, is the most common site for polyps </strong>in this syndrome.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;Esophageal polyps are quite<strong> uncommon in Peutz-Jeghers syndrome</strong>, with the condition typically affecting the small intestine.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Jejunum </strong>is the<strong> most common site </strong>for the characteristic<strong> hamartomatous polyps of Peutz-Jeghers syndrome.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">Location of Polyps in PJS:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_x5vzrZQ.png\" width=\"1033\" height=\"293\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref:</u> Robbins 10<sup>th</sup>/ 809</strong></span></p>",
    "correct_choice_id": 59060,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14739,
    "choices": [
      {
        "id": 58917,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Wheat</span></p>"
      },
      {
        "id": 58918,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Barley</span></p>"
      },
      {
        "id": 58919,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Maize</span></p>"
      },
      {
        "id": 58920,
        "text": "<p><span style=\"font-size:12pt;\">Rye</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The following cereals should be avoided in patients with celiac diseases, except:</span></p>",
    "unique_key": "Q6463463",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191833,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Maize (Ref: Robbins 10<sup>th</sup> /785)</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:black;font-size:12pt;\">It is a disease characterized by <strong>increased sensitivity to a protein called gliadin </strong>present in the grains lik<strong>e wheat; oat, barley and rye </strong>resulting in a <strong>T-cell me\u00addiated chronic inflammatory reaction </strong>in the small intestine and<strong> impaired absorption</strong>. It is associated with <strong>HLA-DQ2 or HLA-DQ8.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:black;font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\">In<strong> celiac disease</strong>, the consumption of grains <strong>containing gluten </strong>should be avoided. <strong>Gluten is a protein found </strong>in:</span></p><p style=\"text-align:justify;\">&nbsp;</p><ol><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Wheat</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Barley</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Rye</span></p></li></ol><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup> /785</strong></span></p>",
    "correct_choice_id": 58919,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14688,
    "choices": [
      {
        "id": 58713,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Mucosa</span></p>"
      },
      {
        "id": 58714,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Mucosa and submucosa</span></p>"
      },
      {
        "id": 58715,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Muscularis propria</span></p>"
      },
      {
        "id": 58716,
        "text": "<p><span style=\"font-size:12pt;\">Serosa</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12.0pt;\">A 63-year-old male with a history of chronic gastritis presents with weight loss and early satiety. An endoscopy with biopsy is performed, revealing a 2 cm lesion in the antrum of the stomach. Histopathology reports a well-differentiated adenocarcinoma. Additional staining shows the cancer is confined to the gastric wall with no evidence of metastasis. </span><span style=\"font-size:12.0pt;\">In early gastric carcinoma, the malignancy is confined to which of the following layers?&nbsp;</span></p>",
    "unique_key": "Q3245730",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191834,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) Mucosa and submucosa</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\">Involvement of both the<strong> mucosa and submucosa</strong> suggests a <strong>deeper invasion</strong> than option A but still within the <strong>confines of the</strong> <strong>stomach wall</strong>, representing an <strong>intermediate stage of disease.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option A.&nbsp;</strong>If a gastric carcinoma is <strong>confined to the mucosa</strong>, it indicates that the <strong>tumor has not penetrated beyond the innermost layer of the stomach</strong>, which is associated with a <strong>less aggressive disease </strong>and often a more favorable prognosis.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option C.&nbsp;Penetration into the muscularis propria </strong>denotes a<strong> more advanced local invasion </strong>compared to options A and B, suggesting a<strong> higher risk </strong>of further <strong>spread and a worse prognosis </strong>if <strong>not treated promptly.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option D.</strong>&nbsp;<strong>Invasion of the serosa</strong>, the<strong> outermost layer of the stomach</strong>, implies that the tumor may be at the stage where it is <strong>capable of spreading beyond the stomach to adjacent structures or through the peritoneal surface</strong>, which would <strong>denote a more advanced and aggressive disease.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\">In <strong>early gastric carcinoma, </strong>the malignancy confined to the <strong>mucosa and submucosa </strong>signifies a <strong>depth of invasion </strong>that is <strong>more advanced than the mucosal layer alone</strong>, but <strong>not yet </strong>extending into the <strong>muscularis propria or serosa</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 775</strong></span></p>",
    "correct_choice_id": 58714,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14655,
    "choices": [
      {
        "id": 58581,
        "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12pt;\">Intestinal dysplasia</span></p>"
      },
      {
        "id": 58582,
        "text": "<p><span style=\"color:black;font-size:12pt;\">Intestinal columnar metaplasia</span></p>"
      },
      {
        "id": 58583,
        "text": "<p><span style=\"color:black;font-size:12pt;\">Simple columnar cell metaplasia</span></p>"
      },
      {
        "id": 58584,
        "text": "<p><span style=\"color:black;font-size:12pt;\">Columnar cell dysplasia</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 55-year-old man with a long history of gastroesophageal reflux disease (GERD) undergoes an upper endoscopy. Biopsy of the distal esophagus shows a change in the normal lining. Which of the following best characterizes Barrett\u2019s esophagus?</span></p>",
    "unique_key": "Q1145776",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191835,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) Intestinal columnar metaplasia</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:12pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:12pt;\"><strong>Intestinal </strong></span><span style=\"font-size:12pt;\"><strong>columnar&nbsp;</strong></span><span style=\"background-color:white;font-size:12pt;\"><strong> metaplasia&nbsp;</strong>This is the <strong>correct </strong>answer.<strong> Barrett's esophagus </strong>is characterized by <strong>intestinal </strong></span><span style=\"font-size:12pt;\"><strong>columnar&nbsp;</strong></span><span style=\"background-color:white;font-size:12pt;\"><strong>metaplasia</strong>, where the<strong> normal stratified squamous epithelium </strong>of the esophagus is replaced with <strong>columnar epithelium containing goblet cells</strong>, as a response to <strong>chronic acid reflux.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:12pt;\"><strong>Option A. Intestinal dysplasia:</strong> This refers to <strong>precancerous </strong>changes within<strong> intestinal epithelium</strong>, which is <strong>not </strong>the finding typically associated with <strong>Barrett's esophagus</strong>. <strong>Dysplasia </strong>in <strong>Barrett\u2019s esophagus </strong>is an important marker for the development of <strong>esophageal adenocarcinoma </strong>but not the characteristic feature of Barrett's itself.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:12pt;\"><strong>Option C. </strong></span><span style=\"font-size:12pt;\"><strong>Simple&nbsp;c</strong></span><span style=\"background-color:white;font-size:12pt;\"><strong>olumnar cell metaplasia:&nbsp;</strong>While<strong> Barrett's esophagus </strong>does involve a change to <strong>columnar epithelium, </strong>the specific subtype with<strong> goblet cells is intestinal metaplasia</strong>, making this option incomplete.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:12pt;\"><strong>Option D. Columnar cell dysplasia:&nbsp;</strong>This would imply a<strong> precancerous change in the columnar cells, </strong>which is not indicated solely by the <strong>presence of Barrett\u2019s esophagus.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:12pt;\"><strong>Barrett's esophagus </strong>is characterized by <strong>intestinal </strong></span><span style=\"font-size:12pt;\"><strong>columnar</strong></span><span style=\"background-color:white;font-size:12pt;\"><strong> metaplasia</strong>, a histopathological change where the <strong>normal squamous epithelium of the lower esophagus </strong>is replaced by <strong>columnar epithelium containing goblet cells</strong>, secondary to <strong>chronic GERD. </strong>This condition necessitates surveillance<strong> due to the increased risk of progression to esophageal adenocarcinoma.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/17/screenshot-2024-04-17-163306.png\" alt=\"\" width=\"500\" height=\"376\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 757</strong></span></p>",
    "correct_choice_id": 58582,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16677,
    "choices": [
      {
        "id": 66668,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is called as Anagen Effluvium</span></span></span></p>"
      },
      {
        "id": 66669,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is an example for Diffuse Hair Loss</span></span></span></p>"
      },
      {
        "id": 66670,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hair does not regrow once the Offending Agent is Stopped</span></span></span></p>"
      },
      {
        "id": 66671,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hair Loss finished within 1-2 Months of Chemotherapy.</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 57-year-old lady diagnosed with Skin malignancy &amp; she underwent chemotherapy, presents with hair loss after 3 weeks of starting of chemotherapy. Identify the INCORRECT statement about this condition?</span></span></span></p>",
    "unique_key": "Q2766209",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191836,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Hair does not regrow once the Offending Agent is Stopped.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. </span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is incorrect. Typically, <strong>hair regrows</strong> after the cessation of chemotherapy, although it may have a <strong>different texture </strong>or<strong> color.</strong></span></span></span><br />\r\n\t&nbsp;</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/23/picture10.jpg\" style=\"height:288px; width:1000px\" /></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. This condition is known as <strong>Anagen effluvium.</strong> Correct:</span></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is hair loss that occurs during the anagen or growth phase of the hair cycle, commonly induced by chemotherapy.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hair regrows&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">once offending <strong>chemotherapy</strong> <strong>agent</strong> is <strong>stopped</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is due to the <strong>anagen, </strong>or<strong> proliferating</strong> <strong>phase</strong> of the <strong>hair cycle</strong> being <strong>adversely affected</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Following the <strong>start</strong> of <strong>chemotherapy</strong>, hair loss usually <strong>starts</strong> within <strong>1-3 week</strong>s and is <strong>finished</strong> within <strong>1-2 months.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. It is an example for Diffuse Hair Loss. <strong>Correct</strong>: </span></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is indeed an example of <strong>Diffuse hair loss</strong>, where hair loss occurs <strong>uniformly</strong> across the <strong>scalp</strong>, often <strong>because</strong> of <strong>systemic treatment</strong> like <strong>chemotherapy</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>D</strong>. Hair loss finished within 1-2 months of chemotherapy. <strong>Correct</strong>:</span></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It typically occurs <strong>rapidly</strong> <strong>after</strong> the <strong>start</strong> of <strong>chemotherapy </strong>and can <strong>continue</strong> for a <strong>short period</strong> <strong>after</strong> the therapy has <strong>concluded</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/23/picture11.jpg\" style=\"height:359px; width:1000px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chemotherapy-<strong>induced hair loss</strong>, or <strong>Anagen effluvium</strong>, is a type of <strong>Diffuse hair loss</strong> that generally <strong>resolves</strong> <strong>after</strong> the <strong>completion</strong> of <strong>chemotherapy</strong>, with hair <strong>regrowth</strong> occurring over time.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Rooks Textbook of Dermatology - 9th Edition Chapter 89 Page No 89.7, 89.48</span></strong></span></span></p>",
    "correct_choice_id": 66670,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7749,
    "choices": [
      {
        "id": 30964,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muehrcke&rsquo;s lines</span></span></span></p>"
      },
      {
        "id": 30965,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beau&#39;s lines</span></span></span></p>"
      },
      {
        "id": 30966,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lindsay nails</span></span></span></p>"
      },
      {
        "id": 30967,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Terrys nails</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The following lines are NOT a pattern of apparent leukonychia?</span></span></p>",
    "unique_key": "Q6063107",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191837,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Beau&#39;s lines</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beau&#39;s lines&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are <strong>generalised transverse grooves&nbsp;</strong>&amp; indentations on the <strong>nail </strong>which is <strong>either full</strong> or of <strong>partial thickness</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They usually occur a <strong>few weeksafter</strong> the precipitating <strong>systemic event</strong> like <strong>MI</strong>, <strong>measles</strong>, <strong>mumps</strong> or <strong>pneumonia.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beau&#39;s lines are not associated with leukonychia.</span></span></span><br />\r\n\t&nbsp;</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beau&#39;s Lines / Transverse Grooves:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/picture6_9Tanelo.jpg\" style=\"height:523px; width:500px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. </span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muehrcke&rsquo;s lines&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">have <strong>multiple transverse white bands</strong>, <strong>parallel</strong> to <strong>lunula</strong>. They are specific finding of <strong>hypoalbuminemia.</strong> They are <strong>reversible</strong> with <strong>albumin infusion</strong>.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/picture7_DvX0BiG.jpg\" style=\"height:334px; width:500px\" /></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><a href=\"https://en.wikipedia.org/wiki/Muehrcke's_nails#/media/File:Muehrcke's_lines.JPG\" style=\"color:#467886; text-decoration:underline\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">https://en.wikipedia.org/wiki/Muehrcke&#39;s_nails#/media/File:Muehrcke&#39;s_lines.JPG</span></a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lindsay nails or half &amp; halfnails</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. The <strong>proximal portion</strong> of the nail is <strong>white&nbsp;</strong>&amp; the <strong>distal half</strong> is <strong>pink</strong> with a <strong>sharp line</strong> of <strong>demarcation</strong> between the <strong>two halves</strong>. They are specific for <strong>renal failure.</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/21/picture8_3AyMC4t.jpg\" style=\"height:422px; width:500px\" /></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><a href=\"https://commons.wikimedia.org/wiki/File:Lindsays_Nails_2.jpg\" style=\"color:#467886; text-decoration:underline\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">https://commons.wikimedia.org/wiki/File:Lindsays_Nails_2.jpg</span></a></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Terry&rsquo;s nails&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">that are entirely <strong>white except</strong> for a <strong>small band</strong> of <strong>pink</strong> or <strong>brown</strong> at the <strong>tip</strong> are <strong>Terry&#39;s nails</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/image_CRfpehM.png\" style=\"height:341px; width:360px\" /></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><u>Educational Objective:</u></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muehrcke&rsquo;s Lines, Lindsay Nails, Terrys Nails</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are examples of <strong>Apparent Leukonychia</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>In Apparent Leukonychia, Pathology is predominant in the nail bed. These lines do not migrate with the growth of the nail.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rooks Textbook of Dermatology- 9th Edition Chapter 95 Page No 95.11, 95.14</span></strong></span></span></p>",
    "correct_choice_id": 30965,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13515,
    "choices": [
      {
        "id": 54021,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Telomerase lengthening</span></span></span></p>"
      },
      {
        "id": 54022,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lamin mutation</span></span></span></p>"
      },
      {
        "id": 54023,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lipid peroxidation</span></span></span></p>"
      },
      {
        "id": 54024,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">DNA helicase defect</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the etiology of Werner syndrome?</span></span></span></p>",
    "unique_key": "Q9243195",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191838,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) DNA helicase defect</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong>&nbsp;</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Werner syndrome </strong>in patients presents with <strong>premature aging, and the defective gene </strong>product is a <strong>DNA helicase</strong>, a protein involved in <strong>DNA replication and repair </strong>and other functions<strong> requiring DNA unwinding</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A defect in this enzyme causes r<strong>apid accumulation of chromosomal damage </strong>that may<strong> mimic the injury that normally accumulates during cellular aging</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:24px; text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Werner syndrome </strong>is caused by a defect in a <strong>DNA helicase enzyme, </strong>which is critical for <strong>DNA replication and repair. </strong>This defect leads to <strong>chromosomal damage and premature aging.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Telomerase lengthening </strong>is typically related to <strong>cellular mechanisms </strong>that allow for<strong> unlimited replication, </strong>as seen in <strong>cancer cells</strong>, not premature aging.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.<strong> Mutations in the lamin proteins </strong>are related to various disorders, including some forms of <strong>premature aging, </strong>but <strong>not specifically Werner syndrome</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> While lipid peroxidation </strong>can contribute to <strong>cellular damage and aging</strong>, it is not the genetic etiology of Werner syndrome.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The genetic etiology of <strong>Werner syndrome is a defect in DNA helicase </strong>leading to premature aging <strong>due to the inability to properly replicate and repair DNA, </strong>which results in accelerated <strong>chromosomal damage.</strong></span></span></span></p>",
    "correct_choice_id": 54024,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13523,
    "choices": [
      {
        "id": 54053,
        "text": "<p><span style=\"font-size:12pt;\">1-d, 2-b, 3-a, 4-c</span></p>"
      },
      {
        "id": 54054,
        "text": "<p><span style=\"font-size:12pt;\">1-d, 2-c, 3-a, 4-b</span></p>"
      },
      {
        "id": 54055,
        "text": "<p><span style=\"font-size:12pt;\">1-b, 2-c, 3-d, 4-a</span></p>"
      },
      {
        "id": 54056,
        "text": "<p><span style=\"font-size:12pt;\">1-b, 2-d, 3-a, 4-c</span></p>"
      }
    ],
    "text": "<p style=\"margin-left:-11px;text-align:justify;\"><span style=\"font-size:12pt;\">Match the type of necrosis and associated disease:</span></p><p style=\"margin-left:-11px;text-align:justify;\">&nbsp;</p><p style=\"margin-left:-11px;text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture10.jpg\" alt=\"\" width=\"700\" height=\"135\"></span></p><p style=\"margin-left:-11px;text-align:justify;\">&nbsp;</p><p style=\"margin-left:-11px;text-align:justify;\">&nbsp;</p>",
    "unique_key": "Q3163432",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191839,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) 1-d, 2-b, 3-a, 4-c</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_d3wGbhy.png\" width=\"761\" height=\"415\"></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The correct matches for the type of necrosis and associated disease are:</span></p><ol><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Caseous necrosis \u2014 d. Mycobacterial infection</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Fibrinoid necrosis \u2014b. Polyarteritis nodosa</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Liquefactive necrosis \u2014a. Staphylococcus aureus infection</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Fat necrosis \u2014 c. Acute pancreatitis</span></p></li></ol><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Robbins and Cotran Pathologic Basis of disease 10th ed (Latest)- Pg: 41</strong></span></p>",
    "correct_choice_id": 54053,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16636,
    "choices": [
      {
        "id": 66504,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Parakeratosis is seen in Psoriasis</span></span></span></p>"
      },
      {
        "id": 66505,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acantholysis is seen in Bullous Pemphigoid</span></span></span></p>"
      },
      {
        "id": 66506,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Spongiosis is seen in Acute Eczema</span></span></span></p>"
      },
      {
        "id": 66507,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acanthosis is the thickening of Stratum Spinosum</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Identify the FALSE statement among the following?</span></span></span></p>",
    "unique_key": "Q9262079",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191840,
    "difficulty_level": "intermediate",
    "subjects_id": [
      18
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Acantholysis is seen in Bullous Pemphigoid</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: Bullous pemphigoid&nbsp;</span></strong><span style=\"font-size:12.0pt\">which is a <strong>subepidermal blistering</strong> &nbsp;disorder, does <strong>NOT</strong> exhibit <strong>acantholysis</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Acantholysis&nbsp;</span></strong><span style=\"font-size:12.0pt\">is the breakdown of intercellular connections, such as <strong>desmosomes</strong>, which causes <strong>keratinocytes</strong> to become <strong>less cohesive</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acantholytic cells/<strong>Tzanck cells </strong>are Circular, Prominent Nucleus with Peri-nuclear Halo</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\u200b\u200b\u200b\u200b\u200b\u200b\u200b&nbsp;&nbsp;&nbsp;&nbsp;\u200b\u200b\u200b\u200b\u200b\u200b\u200b&nbsp;&nbsp;&nbsp;&nbsp;\u200b\u200b\u200b\u200b\u200b\u200b\u200b&nbsp;&nbsp;&nbsp;&nbsp;<img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/17/image.png\" style=\"height:233px; width:530px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Acantholysis</span></strong><span style=\"font-size:12.0pt\"> is classified as</span></span></span>&nbsp;-</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/20/screenshot-2024-02-20-101138.jpg\" style=\"height:324px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A: Actinic keratosis and psoriasis&nbsp;</span></strong><span style=\"font-size:12.0pt\">frequently exhibit parakeratosis, which is suggested by <strong>nucleated stratum corneum</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The term &quot;<strong>parakeratosis</strong>&quot; describes an <strong>abnormal keratinization process</strong> in which <strong>basal layer</strong> cells divide <strong>quickly</strong>, reaching the <strong>stratum corneum faster</strong> and <strong>failing</strong> to <strong>shed</strong> their <strong>nuclei</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">As a result, the <strong>nucleated stratum corneum</strong> is observed on <strong>histopathology</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Parakeratosis (nucleated stratum corneum)&nbsp;</span></strong><span style=\"font-size:12.0pt\">can be seen in the below image pointed by black arrows.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/20/picture11_wpH4oC1.jpg\" style=\"height:640px; width:300px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C: Spongiosis&nbsp;</span></strong><span style=\"font-size:12.0pt\">is the characteristic histopathological feature of <strong>acute eczema</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Intercellular edema&nbsp;</span></strong><span style=\"font-size:12.0pt\">involving the stratum <strong>spinosum</strong> is characteristic of spongiosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/20/picture12_8To9Sjh.jpg\" style=\"height:479px; width:300px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D: Acanthosis&nbsp;</span></strong><span style=\"font-size:12.0pt\">is characterised by an increase in the number of stratum <strong>spinosum</strong> cells, leading to its increased <strong>thickness</strong>. Other histological changes like <strong>Hypergranulosis</strong>, <strong>Hyperkeratosis, </strong>and<strong> Papillomatosis</strong> are frequently present in patients with acanthosis. It appears in <strong>Lupus Vulgaris</strong>, <strong>Verruca Vulgaris</strong>, and <strong>Chronic Eczema</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Below is an illustration of acanthosis. Notice the <strong>increased thickness</strong> of the <strong>Malpighian layer</strong> &amp; <strong>elongated rete ridges</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/20/picture13_2gFfgvp.jpg\" style=\"height:225px; width:300px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Acantholysis</strong> is a feature of <strong>Pemphigus Vulgaris</strong>, not Bullous Pemphigoid, while <strong>parakeratosis</strong> is a hallmark of <strong>psoriasis</strong>, <strong>spongiosis</strong> is characteristic of <strong>acute eczema</strong>, and <strong>acanthosis</strong> indicates the <strong>thickening</strong> of the stratum <strong>spinosum.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref:&nbsp;</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rooks Textbook of Dermatology- 9<sup>th</sup> Edition: Volume 1 Chapter 3, Page No 3.33, 3.38</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><a href=\"https://dermnetnz.org/topics/eczema-pathology\" style=\"color:#0563c1; text-decoration:underline\">https://dermnetnz.org/topics/eczema-pathology</a></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><a href=\"https://en.wikipedia.org/wiki/File:Spongiotic_dermatitis_(2)_Dyshidrotic.JPG\" style=\"color:#0563c1; text-decoration:underline\">https://en.wikipedia.org/wiki/File:Spongiotic_dermatitis_(2)_Dyshidrotic.JPG</a></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><a href=\"https://commons.wikimedia.org/wiki/File:Micrograph_of_early_actinic_keratosis_with_parakeratosis.jpg\" style=\"color:#0563c1; text-decoration:underline\">https://commons.wikimedia.org/wiki/File:Micrograph_of_early_actinic_keratosis_with_parakeratosis.jpg</a></span></span></span></p>",
    "correct_choice_id": 66505,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14130,
    "choices": [
      {
        "id": 56481,
        "text": "<p><span style=\"font-size:12pt;\">Increased turnover of extracellular matrix proteoglycans</span></p>"
      },
      {
        "id": 56482,
        "text": "<p><span style=\"font-size:12pt;\">Exuberant formation of granulation tissue</span></p>"
      },
      {
        "id": 56483,
        "text": "<p><span style=\"font-size:12pt;\">Increased growth of capillary endothelial cells</span></p>"
      },
      {
        "id": 56484,
        "text": "<p><span style=\"font-size:12pt;\">Maturation arrest of collagen assembly</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old woman presents with a painless lesion on her ear lobe (shown in the image) after getting her ears pierced 3 months ago. Which of the following best explains the pathogenesis of this lesion?</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/06/picture1.jpg\" alt=\"\" width=\"300\" height=\"168\"></span></p>",
    "unique_key": "Q7951746",
    "question_audio": null,
    "question_video": null,
    "map_id": 19191841,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D)</strong>&nbsp;<strong>Maturation arrest of collagen assembly</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Keloid </strong>is a scar that tends to<strong> progress beyond the site of initial injury </strong>and <strong>recurs after excision</strong>. <strong>Dark-skinned persons </strong>are <strong>more frequently affected by keloids </strong>than light-skinned people. Keloids are characterized by <i><strong>changes in the ratio of type III to type I collagen</strong></i>, suggesting a <strong>\u201cmaturation arrest\u201d </strong>in the healing process.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">This is the hallmark of <strong>keloid formation</strong>. In keloids, there is an <strong>overproduction of collagen type I </strong>which is unable to reorganise itself into a proper scar. This results in a<strong> thickened and raised scar </strong>that grows <strong>beyond the boundary of the original wound</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.&nbsp;</strong>While<strong> extracellular matrix components</strong>, including <strong>proteoglycans, </strong>play a role in <strong>wound healing</strong>, their turnover is not the primary defect in keloid formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;<strong>Granulation tissue </strong>is the<strong> new connective tissue and microscopic blood vessels </strong>that form on the <strong>surfaces of a wound during the healing process</strong>. <strong>Exuberant granulation tissue </strong>can lead to<strong> hypertrophic scars</strong>, which are <strong>similar to keloids </strong>but do not grow beyond the boundaries of the original wound.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.&nbsp;</strong>This process is more related to the <strong>formation of granulation tissue </strong>during wound <strong>healing</strong>. Although it is an essential part of the healing process, it does not specifically lead to keloids.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>In keloids</strong>, there is an imbalance in the <strong>synthesis and degradation of collagen</strong>, with an <strong>increase in the ratio of type I to type III collagen</strong>. This suggests a<strong> failure </strong>in the normal <strong>maturation process </strong>of <strong>collagen during wound healing</strong>, leading to the<strong> excessive scar formation typical of keloids</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref:</strong> https://journals.lww.com/prsgo/fulltext/2013/07000/keloids_and_hypertrophic_scars__update_and_future.5.aspx</span></p>",
    "correct_choice_id": 56484,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  }
];
        let quizName = '00089 Mid Day Module (Derma+Patho-1)';
        const quizFilename = '00089-mid-day-module-derma-patho-1-2dc48c14.html';
        let hierarchy = ["Cerebellum", "Mock Test", "Mid Day Module"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on navigation
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>